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ABSTRACT 
The eukaryotic cell nucleoplasm is separated from the cytoplasm by the nuclear 
envelope. This compartmentation of eukaryotic cells requires that all nuclear 
proteins must be transported from the cytoplasm into the nucleus. Transport of 
macromolecules between the nucleus and the cytoplasm occurs through nuclear pore 
complexes (NPCs), large protein complexes that penetrate and fuse the nuclear 
envelope. NPCs are freely permeable to small molecules (such as metabolites and 
water) but they restrict the movement of larger molecules to those containing 
specific transport signals. Proteins to be targeted into the nucleus by the classical 
nuclear import system contain arginine/lysine-rich nuclear localization signals 
(NLSs), which are recognized by importin α, the NLS receptor. Importin α binds to 
importin β, which docks the importin-cargo complex on the cytoplasmic side of the 
NPC and mediates the movement of the complex into the nucleus. Presently six 
human importin α isoforms have been identified: importin α1, α3, α4, α5, α6 and 
α7. Many intracellular signal transduction pathways are regulated by controlling the 
nuclear localization of specific proteins. 
Transcription factors are among the most important regulators of gene expression in 
eukaryotic organisms. Transcription factors bind to specific DNA sequences on 
target genes. These sequences are usually located in the promoter regions preceding 
the gene, and the binding of transcription factors to these sites modulates the activity 
of the target gene. Many transcription factors, including signal transducers and 
activators of transcription (STAT) and nuclear factor κB (NF-κB), reside in the 
cytoplasm in an inactive form, and upon activation they are rapidly transported into 
the nucleus. In the nucleus STATs and NF-κB regulate the activity of genes whose 
products are critical in controlling numerous cellular and organismal processes, such 
as inflammatory and immune responses, cell growth, differentiation and survival.  
The aim of this study was to investigate the nuclear import mechanisms of STAT 
and NF-κB transcription factors. This work shows that STAT1 homodimers and 
STAT1/STAT2 heterodimers bind specifically and directly to importin α5 molecule 
  
via unconventional dimer-specific NLSs. The results of this work further suggest 
that two of these NLS elements, one in each monomer, have to be intact for STAT1 
homodimers and STAT1/STAT2 heterodimers to be recognizable by importin α5 
and subsequent nuclear import to take place. Moreover, we found that importin α5-
STAT complex is composed of one STAT dimer and two importin α5 molecules. 
Importin α molecules have two regions, which have been shown to directly interact 
with the amino acids in the NLS of the cargo molecule. The Arm repeats 2-4 
comprise the N-terminal NLS binding site and Arm repeats 7-8 the C-terminal NLS 
binding site.  In this work it is shown that the binding site for STAT1 homodimers 
and STAT1/STAT2 heterodimers is composed of Arm repeats 8 and 9 of importin 
α5 molecule.  
The results in this work are the first to demonstrate interactions between importin α 
molecules and NF-κB proteins. This work demonstrates that all NF-κB proteins are 
transported into the nucleus by importin α molecules. In addition, NLS was 
identified in RelB protein. The interactions between NF-κB proteins and importin α 
molecules were found to be directly mediated by the NLSs of NF-κB proteins. 
Furthermore, this study shows that the classical and the alternative NF-κB pathway 
components have somewhat different specificities for importin α isoforms. 
Moreover, we found that p50 binds to the N-terminal and p65 to the C-terminal NLS 
binding site of importin α3. The results in this work show that the nuclear import of 
p52/RelB dimers is exclusively mediated by the NLS of RelB protein, whereas the 
nuclear import of p52/p65 dimers is solely regulated by the NLS of p52 protein.  
The results from this thesis work identify previously uncharacterized mechanisms in 
nuclear import of STAT and NF-κB. These findings provide new insights into the 
molecular mechanisms regulating the signalling cascades of these important 
transcription factors from the cytoplasm into the nucleus to the target genes. 
 
Keywords: transcription factor, nuclear transport, nuclear localization signal, NLS, 
importin, STAT, NF-κB 
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TIIVISTELMÄ 
Tumakalvo erottaa eukaryoottisolun nukleoplasman sytoplasmasta. Tämän vuoksi 
kaikki sytoplasmassa tuotetut tumaproteiinit kuljetetaan tumakalvolla sijaitsevien 
tumahuokosten kautta sytoplasmasta tumaan. Tumakuljetus on aktiivinen 
tapahtuma, johon osallistuvat tumahuokosten proteiinit sekä erityiset 
kuljettajaproteiinit. Tumalokalisaatiosignaalit (nuclear localization signals; NLSs) 
välittävät tumaan kuljetettavien proteiinien tunnistusta. Yleisimmin NLS-signaalit 
ovat lyhyitä, emäksisiä aminohappoja sisältäviä jaksoja tumaan kuljetettavissa 
proteiineissa. NLS-signaalin tunnistaa α-importiini, NLS-reseptori, joka puolestaan 
sitoutuu β-importiiniin. β-importiini on kuljetusproteiini, joka välittää tumaan 
kuljetettavan proteiinin ja α-importiinin muodostaman kompleksin sitoutumisen 
tumahuokoseen ja siirtymisen tumaan. Ihmisellä α-importiini-molekyylejä on 
tunnistettu kuusi erilaista alatyyppiä: α1-, α3-, α4-, α5-, α6- ja α7-importiinit. 
Useissa solunsisäisissä signaalinvälitysreiteissä tiettyjen proteiinien tumakuljetuksen 
säätely on hyvin keskeistä.   
Transkriptiotekijät ovat tärkeimpiä geenien ilmentymiseen vaikuttavia molekyylejä. 
Transkriptiotekijät sitoutuvat tarkoin määrättyihin säätelyjaksoihin DNA-
molekyylissä ja vaikuttavat geenien ilmentymiseen. Kyseiset säätelyjaksot 
sijaitsevat yleisimmin geeniä edeltävillä promoottorialueilla. Useat 
transkriptiotekijät, kuten sytokiinien indusoimat signal transducers and activators of 
transcription (STAT) ja nuclear factor κB (NF-κB), esiintyvät sytoplasmassa 
inaktiivisina ja aktivoiduttuaan kulkeutuvat nopeasti tumaan saaden aikaan 
muutoksia geenien ilmentymisessä. STAT- ja NF-κB-transkriptiotekijät ovat hyvin 
tärkeitä geenien toiminnan säätelijöitä mm. elimistön puolustusjärjestelmässä 
viruksia ja mikrobeja vastaan, solujen kehittymisessä ja erilaistumisessa sekä 
solukuoleman säätelyssä.  
Tässä työssä selvitimme STAT- ja NF-κB-transkriptiotekijöiden tumakuljetusta. 
Ensimmäisessä ja toisessa osatyössä tutkimme STAT1- ja STAT2-proteiinien 
sitoutumista α5-importiiniin. Ensimmäisessä osatyössä osoitimme STAT1-
  
homodimeerien ja STAT1/STAT2-heterodimeerien sitoutuvan suoraan α5-
importiiniin epätavallisten, rakenteellisten NLS-signaalien välityksellä. Lisäksi 
havaitsimme STAT/α-importiini-kompleksin koostuuvan yhdestä STAT-dimeeristä 
ja kahdesta α5-importiinista. Mutaatioanalyysillä selvitimme lisäksi, että 
aktiivisessa STAT-dimeerissä molempien STAT-proteiinien NLS-signaalien on 
oltava toiminnallisia, jotta dimeeri kykenee sitoutumaan α5-importiiniin ja 
siirtymään tumaan. 
Toisessa osatyössä selvitimme STAT1- ja STAT2-proteiinien sitoutumiskohtia α5-
importiinissa. α-importiinissa on kaksi aluetta, joiden on aiemmin osoitettu suoraan 
sitoutuvan tumaan kuljetettavien proteiinien NLS-signaalien aminohappoihin. Nämä 
alueet koostuvat α-importiinin N-terminaalisista Arm 2-4 -toistojaksoista, sekä C-
terminaalisista Arm 7-8 -toistojaksoista. Selvitimme STAT1-homodimeerien ja 
STAT1/STAT2-heterodimeerien sitoutuvan α5-importiinin Arm 8 ja 9 -
toistojaksoihin.  
Kolmannessa ja neljännessä osatyössä tutkimme NF-κB-proteiiniperheen 
tumakuljetusta. NF-κB-proteiinien ja α-importiinien välisiä interaktioita ei 
aikaisemmin ole osoitettu. NF-κB-perheen proteiineista p50:n, p52:n, p65:n ja c-Rel:n 
on osoitettu sisältävän yksiosaisen NLS-signaalin. Sitä vastoin RelB-proteiinin NLS-
signaalia ei ole tunnistettu. Tutkimuksemme osoitti kaikkien NF-κB-proteiinien 
sitoutuvan suoraan α-importiineihin NF-κB-proteiineissa olevien NLS-signaalien 
välityksellä. Mutaatioanalyysi osoitti p50-proteiinin sitoutuvan α3-importiinin N-
terminaaliseen Arm 3 -toistojaksoon ja p65-proteiinin C-terminaalisiin Arm 7 - ja Arm 
8 -toistojaksoihin. Lisäksi tunnistimme RelB-proteiinista NLS-signaalin. 
Tutkimuksemme osoitti myös, että RelB/p52-dimeerin tumakuljetus välittyy 
ainoastaan RelB-proteiinin NLS-signaalin kautta, kun taas p52/p65-dimeerin 
tumakuljetus on riippuvainen ainoastaan p52-proteiinin NLS-signaalista. 
Tässä väitöskirjatyössä identifioimme aiemmin tuntemattomia STAT- ja NF-κB-
transkriptiotekijöiden tumakuljetustapahtumia. Tämä väitöskirjatyö syventää 
tietämystä molekylaarisista mekanismeista signaalinvälitysreiteissä, jotka välittävät 
STAT- ja NF-κB-transkriptiotekijöiden siirtymistä sytoplasmasta tumaan 
kohdegeenien säätelyalueille. 
 
Avainsanat: transkriptiotekijä, tumakuljetus, tumalokalisaatiosignaali, NLS, 
importiini, STAT, NF-κB 
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ABBREVIATIONS 
AMP  adenosine monophosphate 
AMPK  AMP-activating kinase 
ARD  ankyrin repeat domain 
Arm  armadillo repeat domain 
BAFF  B cell-activating factor 
CD  cluster of differentiation 
cDNA  complementary DNA 
CIS  cytokine induced SH2 protein 
CK  casein kinase 
ER  endoplasmic reticulum 
FCS  fetal calf serum 
FPLC  fast protein liquid chromatography 
GAS  gamma activated sequence 
GAF  gamma activated factor  
GDP  guanidine diphosphate 
GRR  glycine rich region 
GST  glutathione S-transferase 
GTP  guanidine triphosphate 
HIV  human immuno-deficiency virus 
IFN  interferon 
Ig  immunoglobulin 
IB  inhibitor of NF-B 
IKK  inhibitory B kinase 
IL  interleukin 
INM  inner nuclear membrane 
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IRF  interferon regulatory factor 
ISGF  interferon-stimulated gene factor 
ISRE  interferon-stimulated response element  
IU  international unit 
Jak  Janus tyrosine kinase 
LZ  leucine zipper 
LPS  lipopolysaccharide 
mRNA  messenger RNA 
NE  nuclear envelope 
NES  nuclear export signal 
NF-B  nuclear factor kappa-B 
NIK  NF-κB-inducing kinase 
NK  natural killer 
NLS  nuclear localization signal 
NPC  nuclear pore complex 
NTF2  nuclear transport factor 2 
ONM  outer nuclear membrane 
PAGE  polyacrylamide gel electrophoresis 
PAMP  pathogen associated molecular pattern 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PIAS  protein inhibitor of activated STAT 
RanGAP  Ran GTPase activating protein 
RanGEF  Ran guanine nucleotide exchange factor 
RanBP  Ran-binding protein 
RHD  Rel homology domain 
SDS  sodium dodecyl sulphate 
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SH2  Src homology region 2 
SOCS  suppressor of cytokine signalling 
STAT  signal transducer and activator of transcription 
TAD  transcriptional activation domain 
Th  T helper cell 
TLR  Toll-like receptor 
TNF  tumor necrosis factor 
tRNA  transfer RNA 
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1 INTRODUCTION 
The overall process, by which a cell converts one kind of signal or stimulus into 
cellular responses, as well as the individual steps in this process, is termed signal 
transduction. The sensing and processing of stimuli are mediated by signal 
transduction cascades. These molecular networks are constructed from receptors, 
channels, enzymes and regulatory proteins. Cells are highly responsive to signals 
from their environment. Extracellular signalling molecules produce a specific 
response only in target cells, which have receptors for the signalling molecules. 
Binding of a ligand onto its receptor on the cell surface usually causes a 
conformational change in the cytoplasmic domain of the receptor that ultimately 
leads to induction of specific cellular responses. In eukaryotic cells, the response to 
extracellular stimulus often involves the activation of signal transducers by 
phosphorylation cascades via receptor coupled enzymes. In some signalling 
pathways, the receptor itself possesses intrinsic kinase or phosphatase activity, 
whereas in other pathways, the receptor interacts with membrane associated kinases 
or recruits cytosolic kinases to the receptor.  
Signal transduction cascades often result in the control of gene expression. 
Transcription factors are proteins, which bind to DNA and modulate the 
transcriptional activity of the target gene. Human genome encodes more than 
2000 transcription factors. In contrast to general transcription factors that are 
present in all cells and contribute to the synthesis of every mRNA molecule, 
many transcription factors function by specifically identifying promoter-
proximal regulatory elements in a limited number of genes. Many of these site-
specific transcription factors are signal-dependent and sequestered inactive prior 
to receptor stimulation. Signal transducers and activators of transcription 
(STATs) and nuclear factor κB (NF-κB) are site-specific transcription factors, 
which, under unstimulated cellular conditions, are sequestered in the cytoplasm as 
an inactive, latent state. After activation by various extracellular signals, these 
transcription factors rapidly translocate into the nucleus, where they specifically 
modulate the expression of the target genes.    
In eukaryotic cells, the extracellular signal has to be transmitted from the cell 
surface into the nucleus in order to modulate gene expression. The eukaryotic cell 
nucleus is separated from the cytoplasm by the nuclear envelope. Nuclear envelope 
consists of double lipid bilayer membrane that has nuclear pore complexes (NPCs) 
embedded. NPCs are channels that provide the only route of movement of 
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macromolecules into and out of the nucleus. Active nucleocytoplasmic transport of 
macromolecules is mediated by specific import and export systems. The classical 
nuclear import machinery includes importin α (presently 6 human isoforms 
identified) and importin β. Importin α recognizes a mono- or bipartite nuclear 
localization signal (NLS) in the protein to be targeted into the nucleus. Importin α 
binds to importin β, which is responsible for the transport of the importin α-cargo 
complex through the NPC into the nucleus.  
Prior to this thesis study, observations in our laboratory had demonstrated that 
STAT1 and STAT2 proteins have unconventional, dimer-specific NLSs. A few 
years before that, the nuclear import of STAT1 had been proposed to involve the 
function of importin α5 molecule. In NF-κB proteins, monopartite NLSs have been 
identified in p50, p52, p65 and c-rel, whereas the NLS of RelB has remained 
uncharacterized. Prior to this thesis work, there were no published data on the 
possible interactions of NF-κB proteins with importins.  
In order to elucidate the nuclear import mechanisms of STAT and NF-κB 
transcription factors, this thesis work focused on the analysis of the possible 
interactions of STAT and NF-κB with importin α molecules.  
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2 REVIEW OF THE LITERATURE 
2.1 Nuclear transport 
2.1.1 Nuclear envelope  
In eukaryotic cells the transcription machinery of the nucleus is separated from the 
cytosol by nuclear envelope (NE). Since the translation of proteins occurs in the 
cytoplasm, this compartmentation of eukaryotic cells requires that all nuclear 
proteins must be transported from the cytoplasm into the nucleus. In contrast, 
transfer RNAs (tRNA), and messenger RNAs (mRNA) are synthesized in the cell 
nucleus and need to be exported from the nucleus to the cytoplasm for protein 
synthesis. The biogenesis of some molecules, e.g. ribosomes involves multiple 
crossings over the NE. Ribosomal proteins are first synthesized in the cytoplasm and 
then transported into the nucleus where they are assembled with ribosomal RNAs. 
After that the ribonucleoproteins are exported back to the cytoplasm as ribosomal 
subunits. In addition, a great number of molecules shuttle continuously between the 
cell nucleus and the cytoplasm (91).  
The NE is composed of two membrane bilayers named as the outer nuclear 
membrane (ONM) and the inner nuclear membrane (INM). The ONM is continuous 
with endoplasmic reticulum (ER), has functional ribosomes attached and provides 
anchoring sites for structural elements of the cytoplasm. The space enclosed 
between the two nuclear membranes, termed the perinuclear space (10 – 40 nm), is 
also continuous with the lumen of ER and, thus, with the secretory system of the 
cell, but may also have unique functions. The INM has unique characteristics. It 
contains a distinct set of integral and membrane associated proteins that provide 
binding sites for nuclear lamina and chromatin. The nuclear lamina underlies the 
INM. It is a dense network composed of intermediate filament-like proteins called 
lamins and several integral and peripheral lamin-associated proteins. Nuclear lamina 
is essential for nuclear integrity and it also functions in organization of chromatin, 
replication of DNA and regulation of transcription (53, 107, 284). Higher eukaryotes 
have an open mitosis. In animalian cells, NE breaks down during cell division and 
the membrane fragments containing nucleoporins and integral membrane proteins 
disperse to the cytoplasm and nuclear and cytoplasmic compartments become mixed 
(82, 147). At the end of mitosis, NE rapidly reassembles around the decondensing 
chromatin (158). In dividing cells, the compartmentalization of nuclear components 
happens within minutes, whereas the subsequent expansion and maturation of the 
NE takes at least 1h (69). During interphase, however, all macromolecular transport 
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between the cell cytoplasm and the nucleus occurs through nuclear pore complexes 
(NPCs), structures that penetrate and fuse the double bilayer membrane of the NE 
(277) (Figure 1). 
 
 
Figure 1. A schematic representation of the nuclear pore complex (NPC). The main 
structural components of the NPC include the central core framework, 
which is embedded in the double membrane of the nuclear envelope (grey), 
the cytoplasmic fibrills and the nuclear basket. The cytoplasmic fibrills and 
the nuclear basket are mostly composed of the naturally unfolded FG-
nucleoporins, which make direct contacts with the proteins to be transported 
through the NPC.  
2.1.2 Nuclear pore complexes 
NPCs are large multiprotein complexes that form the only direct route for transport 
of macromolecules into and out of the nucleus. With the size of ~50 MDa in yeast 
and up to 125 MDa in vertebrates the NPC is one of the largest assemblies of 
defined macromolecular structures of the cell. Despite of its gigantic size, the NPC 
is composed of only about 30 different proteins, called nucleoporins or Nups, many 
of which are present in multiple copies per NPC (51, 63, 217).  
NPCs provide a diffusion channel for small molecules such as ions and metabolites 
between the nucleus and the cytoplasm but can also mediate the active transport of 
very large complexes, up to several megadaltons in molecular mass such as 
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ribosomal subunits or viral capsids and genomes (129, 216, 281). The diameter of 
the diffusion channel of NPC is ~9 nm, but during an active transport the channel 
opens to a maximum size of approximately 40 nm (203). Passive diffusion is 
extremely slow in the case of bovine serum albumin (68 kDa, 7 nm in diameter), 
relatively inactive for ovalbumin (46 kDa, 6 nm in diameter) and reasonably fast 
only for proteins smaller than 25 kDa (3, 91). Yet, many proteins or RNAs that are 
smaller than 25 kDa, such as histones and tRNAs, normally cross the NPC in an 
active and carrier-mediated fashion (124). The involvment of specific carrier and 
regulatory proteins allows the transport to occur in a controlled fashion. As a whole, 
nuclear transport is a highly organized and an efficient process. Transport through 
NPCs can be supprisingly rapid. For example, it has been presented that a single 
NPC is capable of translocating ~800 transportin molecules (molecular mass 100 
kDa), or up to 2500 nuclear transport factor 2 (NTF2) homodimers (30 kDa) per 
second (222).  
The structure of the NPC can be superficially divided into three basic elements 
(Figure 1): the nuclear basket, the central core (the transporter), which defines the 
maximum channel diameter and the cytoplasmic filaments, which make direct 
contacts with the elements of the cytoskeleton (13). The NPC is crowded with 
nucleoporins characterized by the presence of phenylalanine-glycine (FG)-rich 
motifs. These FG-rich domains are unfolded in their native state and constitute 
nearly half of the nucleoporins. The movement of the cargo across the NPC requires 
direct contacts with these so-called FG-Nups (205, 249, 251). Nuclear transport is 
initiated by an interaction of transport cargo with the cytoplasmic fibrils (import) or 
with the peripheral structures of the nuclear basket (export). The import or export is 
then completed by a series of interactions between the transported cargo-complex 
and NPC interactions over a distance of 100-200 nm, required for complete passage 
from one extreme of the NPC to the other (200, 250). In addition to structural and 
transport-dependent functions of nucleoporins, some of them also have an active 
role in mitosis (23). Furthermore, it has been demonstrated that certain Nups 
associate preferentially with transcriptionally active DNA and interact with the 
promoters of activated genes (266). In spite of their size and complex structure, 
NPCs undergo breakdown and reformation during cell division. 
A proliferating human cell contains approximately 3000-5000 NPCs. NPCs do not 
distribute randomly around the NE, and the number of functional NPCs varies 
depending on the growth state of the cell that in turn affects the overall permeability 
of the nucleus. Moreover, it has been suggested that the protein composition of 
NPCs may vary from one tissue to another, between developmental stages and 
within the NE of a single cell (201, 271). This indicates that the composition of NPC 
can be varied in a manner that may specifically regulate the transport of certain 
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molecules between cytoplasm and nucleus. However, the overall NPC architecture is 
generally conserved across the species from yeast to human (258).   
2.1.3 Receptor mediated nuclear import and export 
The majority of molecules entering or exiting the nucleus are transported through 
the NPC by an active and energy-dependent fashion. Active transport of 
macromolecules between the cytoplasm and the nucleus is carried out by specific 
soluble transport receptors, which mediate the movement of their cargoes through 
the NPC. Apart from NTF2 and TAP/p15 heterodimer, which are the transport 
receptors for RanGTPase and cellular mRNA, respectively, the carriers for actively 
transported macromolecules are collectively referred to as karyopherins, with those 
involved in nuclear import termed importins and those involved in nuclear export 
termed exportins (170). A protein destined for nuclear import or export contains a 
specific signal, a nuclear localization signal (NLS) or nuclear export signal (NES), 
which are regognized by importins and exportins, respectively. Transport of large 
protein complexes through the NPC is fundamentally different from protein import 
to ER or mitochondria, where proteins cross the membrane singly and in a fully 
unfolded state. Moreover, the import signals that direct proteins onto the membranes 
of ER or mitochondria are normally cleaved during the transport event. In contrast, 
specific signal sequences in cargo molecules mediating nuclear import or export are 
not removed (170).  
Karyopherins are members of the highly conserved importin  protein superfamily. 
In human cells the importin β superfamily consists of at least 20 members with 
distinct functions in nuclear transport of specific substrates (186) (Table 1). All 
members of the importin β family have the ability to bind to RanGTPase, which 
provides the metabolic energy and controls the directionality (import vs. export) of 
the transport, to the specific FG-nucleoporins involved in the particular transport 
process, and to a specific set of cargo molecules (42). Karyopherins can bind 
directly to their cargo molecules; however, in many cases the interaction between 
the karyopherin and the cargo is mediated by an adaptor protein.  
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Table 1. Human importin  family members 
Transport factor Cargo 
Import  
Importin  Cargoes with basic NLSs via importin α, 
some cargoes with basic NLSs directly, 
snRNPs via snuportin 
Importin 4 Histones, ribosomal proteins 
Importin 5 Histones, ribosomal proteins 
Importin 7 HIV RTC, Glucocorticoid receptor, 
ribosomal proteins 
Importin 8 SRP19 
Importin 9 Histones, ribosomal proteins 
Importin 11 UbcM2, rpL12 
Transportin 1  hnRNP-A1, histones, ribosomal proteins 
Transportin 2 HuR 
Transportin SR SR proteins 
Export  
Crm1 Leucine-rich NES cargoes 
Exportin-t tRNA 
CAS Importin α 
Exportin 4 eIF-5A 
Exportin 5 Pre-miRNA, tRNA, eEF-1A, ILF3 
Exportin 6 Profilin, actin 
Exportin 7 P50Rho-GAP 
Import/Export  
Importin 13 Import: RBM8, UBC9, Pax6; Export: 
eIF-1A 
Adapted from (42, 207) 
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Importin α-mediated nuclear import 
The best characterized system for active transport of macromolecules between the 
cytoplasm and the nucleus is the classical nuclear import pathway. In this pathway the 
karyopherin mediating the import process is importin  and the adaptor protein 
between the cargo and the karyopherin is importin α (91, 170). The NLS used by the 
classical nuclear import pathway is a short strech of basic amino acids, arginines (R) 
and lysines (K), that lack strict consensus sequence (monopartite NLS) or two clusters 
of basic amino acids separated by a 10-12 amino acids long nonspecific linker 
(bipartite NLS). Original prototypes for the monopartite and bipartite NLSs were 
Simian virus 40 T antigen NLS (PKKKRKV) and the nucleoplasmin NLS 
(VKRPAATKKAGQAKKKKLD), respectively (65, 66, 125, 140). However, at 
present it is known that functional NLSs can be very variable in sequence and 
structure.  
The classical NLS is recognized by importin α. Importin α associates through a 
separate domain with importin β, which is responsible for the docking of the 
importin-cargo complex to the cytoplasmic side of the NPC, followed by 
translocation of the complex through the pore. Passage through the NPC is mediated 
by transient importin -nucleoporin interactions (12, 89, 207). After delivering the 
cargo into the nucleus the cargo-free importin  then translocates rapidly back to the 
cytoplasm via direct contacts with the NPC. Importin α is recycled back to the 
cytoplasm for another round of transport by the exportin CAS (139). 
Importin α molecules have remained structurally and functionally conserved 
throughout evolution and can be found in eukaryotes from yeast to human. In 
humans, only one importin β is known to interact with importin α, while six 
different importin α molecules have been identified: importin α1, importin α3, 
importin α4, importin α5, importin α6 and importin α7 (48, 52, 132, 135, 237). 
Based on their sequence similarity, importin α molecules can be classified into three 
distinct subfamilies, where importin α1 is the only member of one subgroup, 
importin α3 and α4 belong to the other, and importin α5, α6 and α7 comprise the 
third subfamily. All importin α isoforms have the ability to mediate the import of 
NLS-containing substrates into the nucleus. However, these distinct importin α 
molecules are functionally divergent. Although importin α isoforms display 
differencies in their cell- and tissue-specific expression patterns all isoforms exept 
importin α6 are expressed within the same tissues. Importin α6 has been found to be 
expressed only in testis (106, 132, 133, 135, 268). While some substrates can be 
transported into the nucleus by all importin α isoforms, there is a growing number of 
experimental evidence that several substrates are recogniced specifically only by a 
particular, or by a subset of importin α molecules (4, 118, 134, 135, 156, 172, 176, 
196, 214, 238, 270). 
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Figure 2. Three dimensional structure of importin α armadillo (Arm) domains. 
Importin α molecule contains ten Arm repeats, which are shown in different 
colors. The “side view” (left) and the view facing the central groove (right) 
are related by 90° rotations. The molecule was compiled with program 
DeepView and it is based on yeast karyopherin α (Protein Data Bank 
accession number 1bk5).   
The crystal structure of two importin α molecules, yeast importin α and mouse 
importin α2, have been determined (47, 75) (Figure 2). The structure of importin α 
can be divided into three structural units: a central NLS binding domain build by the 
regular stacking of 10 armadillo (Arm) repeats (so named because they were first 
discovered in the Drosophila Arm protein (206)), a small hydrophobic C-terminal 
region, which binds to the exportin CAS, and a positively charged N-terminal 
autoinhibitory domain, which can bind either to the Arm domain (blocking the 
interaction with the NLS of the cargo molecule) or to importin β. Importin α 
molecules have two NLS binding sites, which directly interact with the NLS of the 
cargo. The Arm repeats 2-4 comprise the N-terminal (“the major”) NLS binding site 
and Arm repeats 7-8 the C-terminal (“the minor”) NLS binding site. Each Arm 
repeat consists of approximately 40 amino acids that fold into three α helices. These 
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α helices contain the highly conserved tryptophan and asparagine residues that 
directly interact with the basic amino acids on the NLS of the cargo molecule (47, 
74, 75, 142) (Figure 2).  
 
CRM1-mediated nuclear export  
Nuclear export of proteins is mediated mainly by NESs. NESs are short stretches of 
amino acids containing 5-6 hydrofobic residues (typically leucines), first described 
in the protein kinase A inhibitor, PKI (276). The hydrophobic, leucine-rich NES is 
utilized in all eukaryotes and it is recogniced by the karyopherin Crm1 (also called 
exportin-1) (138). A common example of NES is the NES found in the Rev protein 
of HIV: LQLPPLERLTL (73). This type of leucine-rich NES mediates the binding 
to and export by Crm1, and functions in a great number of proteins. In the nucleus 
Crm1 binds to RanGTP. This interaction induces conformational changes in Crm1 
and activates it for binding to NES-containing cargo. Crm1 docks the complex to the 
FG-Nups on the nuclear side of the NPC, and the complex is transported through the 
NPC by Crm1-nucleoporin interactions analogous to the importin β-mediated 
nuclear import. On the cytoplasmic side of the pore, Ran-bound GTP is hydrolyzed, 
the complex is dissassembled and the cargo is released to the cytoplasm (91, 186) 
(Figure 3B). Like importin β, Crm1 can also mediate the export of some cargoes via 
adapter proteins (207). Crm1 and other exportins interact with their cargoes 
effectively only in the presence of RanGTP.  
 
The RanGTPase system 
The energy for active nuclear transport is provided by the Ras family GTPase Ran 
(215). The RanGTPase is critical in generating the directionality of the transport 
process. The loading and unloading of importins and exportins with their cargo 
molecules is controlled by a concentration gradient of RanGTP across the NE. Like 
all small GTPases, Ran can switch between GTP and GDP-bound state. The GTP-
bound form of Ran is predominantly nuclear, whereas RanGDP is mainly localized 
in the cytoplasm. Directionality of nuclear transport relies on the specific 
interactions between karyopherins and RanGTP. Importins bind effectively to their 
cargoes only in the absence of RanGTP, that is in the cytoplasm. Once in the 
nucleus, importins have a reatively high affinity for the GTP-bound form of Ran. 
The binding of importin to RanGTP leads to the dissociation of the importin-cargo 
complex, and the cargo is released into the nucleus. Ran gradient is critical, because 
cytoplasmic RanGTP would inhibit nuclear import as it would cause the importin-
cargo complexes to dissassemble before they could reach the NPCs. Exportins, on 
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the other hand, form a trimeric complex with RanGTP and their cargo molecules in 
the nucleus. Exportins have a relatively low affinity for Ran in the absence of cargo. 
Exportins are activated for cargo binding by association with RanGTP in the nucleus 
and the complex dissociates upon GTP hydrolysis in the cytoplasm (207, 275) 
(Figure 3). 
 
Figure 3. Overview of nuclear localization signal (NLS)- and nuclear export signal 
(NES)-mediated nuclear transport pathways. (A) Nuclear import of NLS 
cargo mediated via importin α/β. (B) Nuclear export pathways mediating the 
recycling of importin β and importin α back to the cytoplasm. (C) Nuclear 
export of NES cargo mediated by Crm1. (D) Nuclear import of RanGDP 
mediated by nuclear transport factor 2 (NTF2). See text for details.   
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Ran has a low intrinsic activity and it has to interact with additional factors to 
effectively complete the GDP-GTP cycle. Ran GTPase activating protein  
(RanGAP) catalyzes the conversion of RanGTP to RanGDP (21). This GTPase 
activation is further stimulated by Ran-binding protein 1 (RanBP1). RanBP1 and 
RanGAP are excluded from the nucleus and co-operate in the cytoplasm, where 
RanBP1 binds tightly to the GTP-bound form of Ran. RanGAP is situated on the 
cytoplasmic side of the NPC, where it catalyzes the conversion of RanGTP to 
RanGDP. This leads to the dissociation of the exportin-cargo complexes to the 
cytoplasm. Ran has a high efflux rate from the nucleus, more than 105/s/nucleus, due 
to the constantly exiting exportins (246). However, Ran is predominantly distributed 
in the nucleus, and the nuclear RanGTP levels exceed the cytoplasmic concentration 
about 100-fold (92). The import of RanGDP back into the nucleus is mediated by 
NTF2, which binds only to the GDP-bound form of Ran (245). NTF2 mediates the 
rapid translocation of RanGDP from the cytoplasm into the nucleus by direct 
contacts with FG-repeat containing nucleoporins. Ran can also diffuse passively 
across the NPC, and RanGTP (which cannot bind NTF2) traverses NPCs at the same 
rate as RanGDP in the absence of NTF2, that is, very slowly (92). Once in the 
nucleus, RanGDP is converted into RanGTP through the action of guanine 
nucleotide exchange factor RanGEF (also called RCC1). RanGEF is a nuclear 
protein, which is stably bound to chromatin through an interaction with the core 
histones H2A and H2B (195). RanGEF is a very abundant protein, which has been 
estimated to be present in up to one copy per nucleosome (56). After mitosis and the 
mixing of nuclear and cytoplasmic contents, the NE accumulates around the 
decondensing chromatin. The association of RanGEF with chromatin, thus, after the 
formation of NE at the end of the mitosis provides the primary gradient of RanGTP 
in the nucleus (91, 170).  This provides the primary prerequisites for the control of 
the directionality of nuclear transport processes. 
 
Regulation of nuclear transport 
The proper function of many molecules requires that their nuclear or cytoplasmic 
concentration and activity is tightly regulated. Therefore, mechanisms must exist to 
turn the transport of a given cargo on and off.  Since distinct karyopherins posses 
different cargo-recognition mechanisms, one mechanism of regulating a particular 
transport pathway is through controlling the protein expression levels of 
karyopherins themselves. The resulting selection of karyopherins will determine 
what kind of proteins will be targeted into or out of the nucleus (122).  
Cargo molecues can be anchored to an insoluble cellular component. In this form of 
regulated transport, a receptor-cargo complex can form, but cannot be targeted to the 
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NPC. This kind of regulation has been shown to take place with some molecules, such 
as sterol regulatory element binding protein, which is attached to the NE and ER in 
unstimulated cells (124). Upon activation the membrane bound protein undergoes 
proteolytic cleavage to produce a soluble fragment that enters the nucleus. This type of 
regulation is irreversible since the active form cannot be anchored back to the 
membranes by the same mechanism. A recent report suggests that also transport 
receptors can be tethered inactive by immobile components (204). It has been 
suggested that significant proportions of importin β, importin α, NTF2 and Ran are 
not freely diffusing and available for transport functions, but are associated with 
immobile components such as microtubules in the cell cytoplasm (204).  
The transport properties of the NPC can be regulated. It has been suggested that the 
protein composition of the NPC can be varied throughout the cell cycle. This 
indicates that the transport receptor-NPC interactions can be reversibly regulated by 
molecular rearrangements of the NPC (124, 201). It has been suggested that 
modification of RanGAP with SUMOylation at the NPC serves as a mechanism to 
control nuclear transport (159, 209, 210). 
The cargo molecules can be modified in a way that it affects their ability to bind the 
import or export receptor. Prevention of target sequence recognition by 
intramolecular or intermolecular masking of the NLS or NES is one of the most 
common strategies to regulate the efficiency of nuclear transport.  
Controlling of NLS or NES recognition by phosphorylation is a key mechanism of 
regulating nuclear transport processes. Post-translational modification of signalling 
molecules by phosphorylation and dephosphorylation is propably the most common 
and the best understood mechanism known to regulate nuclear transport. Kinases 
and phosphatases can themselves be regulated by many different intracellular and 
extracellular signals. Thus, signal-mediated phosphorylation and dephosphorylation 
to regulate the subcellular localization of molecules provides a direct connection 
from extracellular signals through intracellular signals to the subsequent response in 
terms of nuclear import or export of specific signalling molecules such as 
transcription factors. Many of these transcription factors contain both NLS and NES. 
As a result, their nuclear concentration and activity can be tightly regulated in 
response to a plethora of different types of signals (120, 121, 124).  
2.2 Transcription factors 
Transcription factors are proteins that bind to specific DNA sequences on target 
genes. These DNA sequences are normally located in the promoter regions 
preceeding the targe gene, and the binding of transcription factor to these sites 
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modulates the transcriptional activity of the gene. Transcriptional control of gene 
expression often involves series of signal transduction cascades along the way from 
the cell surface through cell cytoplasm into the nucleus to the target genes. Binding 
of extracellular proteins to cell-surface receptors can change nuclear gene expression 
in minutes. In unstimulated cells many transcription factors, like signal transducer 
and activator of transcription (STAT) and nuclear factor B (NF-B), are 
sequestered in the cytoplasm as inactive, latent forms. After stimulation these factors 
are activated and rapidly translocate into the nucleus where they modulate the 
activity of the target gene. Control of activation by phosphorylation is a common 
mechanism in controlling and regulating the transcriptional activity of many 
transcription factors.   
2.2.1 STATs 
STATs are latent cytoplasmic transcription factors that are activated by a large 
number (>50) of extracellular signalling molecules including cytokines, hormones 
and growth factors (254). STAT proteins have fundamental roles in highly diverse 
biological processes such as mediating host antimicrobial responses and cell 
development, differentiation, proliferation and survival. In addition, constitutively-
activated STAT signalling is associated with malignant progression of many human 
cancers (1, 26). STAT proteins are well conserved in eukaryotic evolution, and 
STAT homologues have been identified in slime mold Dictyostelium, nematode C. 
Elegans and Drosophila (108, 150). Seven STAT proteins have been identified in 
humans: STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b and STAT6 (78, 110, 
151, 233, 289, 298). 
 
Overview of STAT functions  
STAT1, STAT3, STAT5a and STAT5b are activated by many distinct and 
sometimes overlapping ligands, whereas only a few cytokines activate STAT2, 
STAT4 and STAT6. STAT1 is involved in interferon (IFN) signalling and mediates 
antiviral and antibacterial responses, growth inhibition and tumor supression. 
STAT2 is also activated by IFNs and it is essential for antiviral responses of IFN-
/. STAT3 is activated by many cytokines and growth factors including 
interleukin-6 (IL-6) family members and epidermal growth factor. STAT3 is the 
only STAT protein shown to be required for early development as STAT3 null mice 
are embryonically lethal. STAT4 is activated by IL-12 and IL-23 and it is involved 
in regulation of Th1 cell differentiation. STAT5a and STA5b are closely related 
STAT proteins (sharing ~96% sequence identity) that have overlapping but also 
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distinct functions, and these proteins are activated by many IL-2 family cytokines. 
STAT5a is involved in prolactin and STAT5b in growth hormone signalling. STAT6 
is activated by IL-4 and IL-13 and it participates in the regulation of Th2 
development (117, 148, 199, 234, 286). 
STATs have the ability to mediate signals from cell membrane into the nucleus to 
activate gene transcription, thus bypassing the involment of any additional signalling 
cascades between cell-surface receptors and the target genes. STAT proteins form 
active homodimers in response to ligand stimulation. In some cases STATs prefer 
heterodimer formation, e.g. STAT1/STAT2 in response to IFN-α/β activity, 
STAT1/STAT3 in response to IL-6 activity and STAT5a/STAT5b in response to 
growth hormone activity (108). STAT2 is unique in that it has not been found to 
bind DNA as a homodimer. Cytokine stimulation leads to a rapid accumulation of 
active STAT dimers into the nucleus. Once in the nucleus, STAT dimers can 
directly bind to DNA sequences known as -activated sequences (GAS) in the 
promoter regions of cytokine-responsive genes, resulting in modulations of gene 
activity. STAT activation is normally rapid and transient in nature, lasting from 
several minutes to a few hours. The activation is usually quickly down-regulated to 
keep cytokine responses under control. However, it has become apparent that some 
STATs are also involved in controlling constitutive and ligand independent gene 
expression (31). Moreover, it has been shown that STAT1 can also negatively 
regulate certain promoters in response to IFN- (220).  
 
 
 
 
 
 
 
Figure 4. Schematic representation of STAT1 and STAT2 structure. The N-terminal 
end and the coiled coil domain (CC) mediate interactions with various 
proteins. The DNA binding domain (DNA) is located in the middle of the 
molecule followed by a linker domain. SH2 domain interacts with 
phosphotyrosine residue of the other molecule in STAT dimers. 
Transactivation domain (TAD) is located at the C-terminal end and contains 
the conserved tyrosine residue critical for dimer formation.     
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Structure of STAT proteins 
Full-length STAT proteins are between 750 (STAT1) and 851 (STAT2) amino acids 
long and share several functional domains (Figure 4). N-terminal domain (residues 
1-~140) is involved in formation of dimers, tetramers and other higher order 
complexes between STAT family members. This domain also mediates other 
protein-protein interactions e.g. STAT1 with CBP/p300 transcriptional coactivators 
(296). Next from the N-terminus is a coiled coil region (amino acids ~130-315), 
which mediate many protein-protein interactions in solution or on target promoters. 
The coiled coil region of STAT3 has been shown to contain amino acids essential 
for interaction with importin α molecules (156). Two functional NESs have been 
identified in the coiled coil domain of STAT1 (16, 188). Furthermore, coiled coil 
domain of STAT1 and STAT2 have been shown to interact with interferon 
regulatory factor (IRF) 9 (109, 168). The DNA-binding domain at amino acids 
~300-500 contains an immunoglobulin (Ig)-like fold and it resembles that of NF-B 
DNA-binding domain. DNA-binding domains of STAT1, STAT2 and STAT3 
contain amino acids essential for interaction with importin α molecules and 
subsequent nuclear import of activated dimers (156, 172, 177). In addition, yet 
another functional NES of STAT1 has been mapped to the DNA binding domain of 
STAT1 (173). The short linker domain connects the DNA-binding domain to the src 
homology-2 (SH2) domain. SH2 domains are found in a large number of proteins 
involved in signal transduction and these domains function to specifically recognize 
phosphorylated tyrosine residues (185). In all STAT molecules the conserved 
activating tyrosine residue (Tyr701 of STAT1 and Tyr690 of STAT2) closely follows 
the SH2 domain. This conserved tyrosine residue undergoes phosphorylation upon 
activation and forms intermolecular interaction with the SH2 domain of the other 
STAT molecule in the active dimer. Dimerization via tyrosine phosphorylation is 
critical in activation of all STAT dimers. However, STATs are the only transcription 
factors known to be activated by tyrosine phosphorylation. The region from the 
activating tyrosine residue to the C-terminal end comprises the transcriptional 
activation domain (TAD). This is the most diverse domain among STAT proteins. In 
the promoters of target genes the TADs of STATs interact with other proteins 
involved in regulation of gene transcription. NES has been identified in the TAD of 
STAT2 (9). The TAD of STAT1 has been shown to interact with CBB/p300 (296). 
The TADs of STAT1, STAT3, STAT4, STAT5a and STAT5b can be modulated by 
serine phosphorylation to further regulate the transcriptional activities of the proteins 
(57, 150). STAT proteins have been described to undergo proteolytic processing and 
alternative splicing to produce shorter isoforms. The full-length STATs are called as α 
isoforms and the shorter products as ,  or  isoforms (14, 37, 150, 283). The crystal 
structures of several STAT dimers have been determined (14, 37, 163, 194, 283). 
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STAT1 and STAT2 mediated interferon signalling 
The first STATs identified 15 years ago were STAT1 and STAT2. They were 
discovered as targets of IFN activation (78, 233). IFNs are a family of cytokines that 
have the ability to interfere with viral replication and infection. IFNs can be divided in 
three distinct groups: Type I interferons (predominantly IFN-α and -β) are produced 
by many cell types as a first line of defence against viral infections (239). IFN- is the 
only member of type II IFNs. IFN- is produced by natural killer cells and T cells and 
it has multiple effects in the regulation of immune responses involved in 
inflammation, antibody production and viral infection (239). The recently described 
type III interferons consist of IFN-1, IFN-2 and IFN-3 (136, 241). Although type I 
and type III IFNs signal through distinct receptor complexes, both types induce 
STAT1, STAT2 and STAT3, and as a result type III interferons have antiviral 
functions similar to those of type I interferons (299). Binding of interferons to their 
cell surface receptors activates antiviral etc. responses via Janus tyrosine kinase (Jak)-
STAT pathway (55). Jaks are receptor associated tyrosine kinases that posess auto- 
and transphosphorylation functions (148). Presently, four members of Jaks have been 
described in humans: Jak1, Jak2, Jak3 and Tyk2 (290). Jak-STAT pathway is the most 
common and best characterized signalling pathway in response to a wide variety of 
cytokines (292). The intracellular activation of Jak-STAT pathway occurs when ligand 
binding induces the multimerization of receptor subunits.  
Type I and type II interferons signal through distinct but related pathways (Figure 
5). IFN-α/ receptor is composed of two transmembrane receptor chains: IFNα/R1 
and IFNα/R2. The cytoplasmic domains of the receptor subunits are specifically 
and constitutively associated with Tyk2 (IFNα/R1) and Jak1 (IFNα/R2) tyrosine 
kinases. During unstimulated state the receptor subunits are not preassociated with 
one another strongly. Binding of IFN-α/ to its receptor causes dimerization of the 
subunits and brings the receptor associated Jaks into close proximity. This induces 
sequential activation of Tyk2 and Jak1 by auto- and transphosphorylation. Activated 
Tyk2 and Jak1 in turn phosphorylate IFNα/R1 at specific tyrosine residues, 
constructing a docking site for the SH2-domain of STAT2. Next, Tyk2 and Jak1 
phosphorylate receptor-bound STAT2 at Tyr690. This enables the binding of STAT1 
to the receptor. Receptor associated STAT1 is phosphorylated by Jaks at Tyr701, 
which is critical for the formation of the active STAT1/STAT2 heterodimer. Once 
activated, the dimer dissociates from the receptor. The receptor-dissociated 
STAT1/STAT2 heterodimer, together with the dimer associated IRF9, generates the 
active interferon-stimulated gene factor 3 (ISGF3) complex characteristic of IFN-
α/β stimulation. In the nucleus ISGF3 complex binds to the interferon-stimulated 
response element (ISRE) sites on the promoter regions of IFN-α/ responsive genes. 
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The products of these genes induce the primary IFN-α/β induced response for viral 
infections (239, 248).  
 
 
Figure 5. Type I (left) and type II (right) interferon (IFN) signaling. IFN binding to 
its receptor results in heteromerization of the receptor subunits. This 
induces phosphorylation of receptor-associated Jaks and receptor chains. 
STATs bind to the receptor via their SH2 domains. Receptor-bound STATs 
are phosphorylated by Jaks. Phosphorylated STATs form dimers, dissociate 
from the receptor, enter into the nucleus and bind to the promoter regions of 
IFN-responsive genes.  
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The subunits of the IFN- receptor, IFNR1 and IFNR2, are preassociated with 
Jak1 and Jak2, respectively (Figure 5). The active form of IFN- is a homodimer. 
Ligand binding to the IFNR1 subunit leads to the oligomerization of the receptor 
and activation of the receptor-associated kinases by auto- and transphosphorylation. 
Jak2 is activated first and it is needed for the activation of Jak1 (28). Activated Jaks 
in turn phosphorylate the IFNR1 subunit providing an attachment site for STAT1 
via its SH2 domain. Receptor-associated STAT1 molecules are phosphorylated by 
Jaks at Tyr701, which enables the formation of an active STAT1 homodimer, the -
activated factor (GAF). It has been proposed that Jak1 is mainly responsible for the 
receptor phosphorylation, and once STAT1 is bound to the receptor, the 
phosphorylation of STAT1 is mediated by Jak2 (28). Phosphorylated STAT1 
homodimer dissociates from the receptor and the dimer translocates into the nucleus. 
In the nucleus STAT1 homodimers bind GAS sites on interferon -activated genes. 
The transcriptional function of STAT1 homodimers and ISGF3 complexes can be 
further regulated by serine phosphorylation of STAT1 (211). IFN-α/β and IFN- 
have partly overlapping functions because to a certain extent STAT1 homodimers 
are formed upon IFN-α/β stimulation, and also because STAT1 homodimers 
induced by IFN- can also be associated with IRF9 and bind to the ISRE sequences 
(248). In addition, STAT1-independent gene regulation has been described in 
respone to IFN-α/β and IFN- (86, 218, 219). Although a great variety of cytokines 
and cytokine receptor combinations signal through the four Jak molecules and the 
seven STAT proteins, other STAT family members are activated by various 
cytokines similary to STAT1 and STAT2 through receptor oligomerization and 
receptor-associated Jaks, making the IFN signal transduction pathway presented 
above a generic model for STAT-mediated cytokine signalling.   
Originally, the standard model postulated that latent STATs exist as a monomeric 
pool prior to cytokine stimulation (242). However, it has become evident that 
unphosphorylated STATs most likely exist as dimers and probably as tetramers and 
higher order complexes in unstimulated cells (236). First, it was presented that 
STAT3 homodimers and STAT1/STAT3 heterodimers can be 
coimmunoprecipitated from unstimulated cells (94, 198). In addition, large 
multiprotein complexes (up to 1-2 MDa) of STAT3, STAT1, STAT5a and STAT5b 
were identified from Hep3B cells and rat liver cytoplasm prior to cytokine 
stimulation (193). Furthermore, crystallographic analyses of unphosphorylated 
STAT1 revealed a tetrameric conformation (163). However, by further biochemical 
analyses the authors concluded that STAT1 exists predominantly as a dimer prior to 
cytokine stimulation. Moreover, the authors presented two different conformations 
for unphosphorylated STAT1, designated as “parallel” and “antiparallel” models 
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(163, 297). The parallel model was shown to resemble the structure of the tyrosine-
phosphorylated STAT1 homodimer, whereas the antiparallel dimer had a unique 
conformation. The authors further speculated that the antiparallel form is the 
predominant structure in the latent state, whereas the parallel conformation was 
proposed to be the receptor bound form of STAT1 prior to tyrosine phosphorylation. 
Tyrosine phosphorylation upon ligand binding most likely induces a conformational 
change in STAT dimer that causes dissociation of the dimer from the receptor and 
induces a conformation that is recognizable by importin α molecules. 
 
STAT inactivation 
STATs are inactivated in the cytoplasm by several proteins. Supressor of cytokine 
signalling (SOCS) proteins prevent further activation from the receptors by 
interacting with phosphorylated receptor subunits or Jaks (70). SOCS can also 
induce STAT degradation by the ubiquitin-proteasome pathway (137). Cytokine-
induced SH2 protein (CIS) competes with STATs for the same docking sites on the 
receptor (169). In the nucleus, protein inhibitors of activated STATs (PIAS) inhibit 
the DNA binding of active STATs (2), while certain phosphatases have been 
described to dephosphorylate active STATs in the nucleus (263, 285). 
Phosphorylated STATs are not transported back to the cell cytoplasm. Previous 
models of STAT inactivation presented that dephosphorylation releases STATs from 
DNA (97, 248). However, at present it seems that it is the other way round: DNA 
binding protects STATs from dephosphorylation (182, 297). Only upon dissociation 
from the promoter regions STAT dimers are subjected to dephosphorylation. It has 
been proposed that phosphorylated STAT1 dimer undergoes conformational 
rearrangements to the antiparallel form when not bound to DNA. This 
rearrangement of the dimer is most likely required for the efficient presentation of 
phosphorylated STAT1 dimer to the tyrosine phosphatases prior to their nuclear 
export (297). 
 
STAT nucleocytoplasmic transport 
Classical NLSs have not been identified in STATs. The first report of the existence 
of NLS signals in STAT molecules emerged when an unconventional, structural and 
dimer-specific NLS was identified in STAT1 and STAT2 (177). This structural NLS 
is situated in the DNA-binding domain of the molecule, and two of these elements, 
one in each monomer, were shown to be required for nuclear import of STAT1 and 
STAT2. The amino acids required for nuclear import were mapped to lysines 410 
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and 413 of STAT1 and to arginine 409 and lysine 415 of STAT2. Another study has 
described leucine 407 to be essential for STAT1 nuclear import (172). Previously, 
the mechanism that regulates STAT1 nuclear import was shown to involve the 
function of importin α5 (238).  
STAT3 has been shown to contain two distinct arginine-rich sequence elements, 
which are required for its nuclear import (157). These elements are situated in the 
coiled coil (arginines 214 and 215) and DNA-binding (arginines 414 and 417) 
domains of STAT3. The NLSs of STAT1, STAT2 and STAT3 differ from the 
classical NLS signals to some extent. They do not resemble the consensus sequences 
of classical mono- or bipartite NLSs, and they become active only in dimers. 
Recently, it was presented that the nuclear import of STAT3 is mediated by importin 
α5 and importin α7 in a cytokine-stimulation dependent fashion (156). However, it 
has also been suggested that signal-dependent nuclear import of STAT3 is mediated 
by other importin α isoforms (270). In addition, it has been suggested that nuclear 
import of STAT3 is independent of tyrosine phosphorylation and mediated by 
importin α3 (155). Moreover, a valine-rich sequence consisting of amino acids 466-
469 of STAT5b has been proposed to be required for growth hormone-induced 
nuclear accumulation of STAT5b (102). At present, there is no detailed information 
describing the molecular mechanisms of nuclear import of STAT4, STAT5a, 
STAT5b or STAT6.   
It has been suggested that unphosphorylated STATs shuttle continuously between 
the nucleus and cytoplasm. It has also been proposed that the nuclear import of 
unphosphorylated STATs and tyrosine phosphorylated STAT dimers are 
mechanistically distinct from each other (9, 180, 181, 212, 295). These observations 
were confirmed by import assays with digitonin-permeabilized cells, which retain an 
intact NE but are devoid of cytoplasmic proteins, and thus, importins. It was 
revealed that only unphosphorylated STAT1 could enter the nucleus in the absence 
of cytosolic proteins, whereas the nuclear import of tyrosine phosphorylated STAT1 
dimers required metabolic energy and added cytosol (164). Similar results were 
obtained also for unphosphorylated mouse STAT3 and sheep STAT5 (164). In fact, 
the authors further demonstrated that the constitutive nucleocytoplasmic shuttling of 
STAT1 is mediated by direct interactions of STAT1 with the FG-rich nucleoporins 
of the NPC. Thus, it is apparent that STATs use two distinct pathways. Before 
cytokine stimulation, unphosphorylated STATs shuttle in and out of the nucleus in a 
karyopherin-independent mechanism that involves direct contacts with nucleoporins. 
Active nuclear import of tyrosine phosphorylated STATs, instead, is dependent on 
importins and metabolic energy. These distinct pathways are most likely the 
consequence of the conformational differences between the unphosphorylated 
dimers and the phosphorylation-activated STAT dimers.  
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A few years ago, three groups identified a leucine-rich NES in STAT1 (16, 173, 
188). All of these functional export signals were mapped to distinct locations of the 
molecule. Later, multiple functional NES motifs have been identified in STAT3 and 
STAT5b (19, 295). In addition, the carboxyl terminus of STAT2 has been shown to 
contain leucine rich NES, which mediates the nuclear export of STAT2 and 
STAT2/IRF9 complexes (9). The carrier-dependent nuclear export of STATs is 
mediated by the exportin Crm1. But, as for nuclear import, there is evidence for 
carrier-independent nuclear export that proceeds through contacts with the 
nucleoporins (164). The existence of these distinct transport pathways allows the 
controlled nuclear transport to occur during cytokine induction, as well as the 
carrier- and energy-free nucleocytoplasmic cycling to proceed without metabolic 
energy under unstimulated cellular conditions.  However, apart from that model, it 
has been proposed that STAT2 is constitutively associated with IRF9, and the 
nuclear shuttling of unphosphorylated STAT2 has been proposed to be dependent on 
the NLS of IRF9 and on the C-terminal NES of STAT2 (9, 144, 168). However, no 
karyopherins have been associated to the nuclear import of IRF9 so far. 
2.2.2 NF-κB 
NF-B describes a structurally and evolutionary conserved family of ubiquitously 
expressed transcription factors that have important roles in the regulation of a great 
variety of normal cellular and organismal processes, such as immune and 
inflammatory responses, developmental processes, cell proliferation, differentation 
and apoptosis (7, 85, 100). In addition, dysregulation of NF-B has been associated 
in a number of common diseases including cancer, chronic inflammation, 
neurodegenerative diseases and diabetes (8, 49, 178, 221, 235). NF-B was initially 
identified more than 20 years ago as a DNA-binding factor for the enhancer of the Ig 
 light-chain in activated B cells (240). However, as it is known today, NF-B is 
neither a critical regulator of B light gene nor it is B cell specific. NF-B is a 
stimulus-responsive pleiotropic regulator of gene control present in all cell types.  
NF-B is activated by a great variety of physiological and nonphysiolocical stimuli, 
including bacterial, viral and fungal products as well as inflammatory cytokines, 
oxidative stress, ultraviolet and ionizing radiation and genotoxic drugs (202). 
Moreover, nearly 800 inhibitors of NF-B signalling have been identified so far, 
including a large variety of natural and synthetic molecules (87). In most 
unstimulated and untransformed cells, NF-B is sequestered in the cytoplasm in an 
inactive, latent state by association with inhibitor of NF-B (IB) molecules (6, 
280). The activation of NF-B is controlled mainly via its nuclear localization. Upon 
stimulation, NF-B is activated in most cases through the IB kinase (IKK) 
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complex-dependent phosphorylation of IκB proteins and subsequent degradation of 
IBs from the IκB/NF-κB complexes by the ubiquitin-proteasome system (40, 128, 
232). The IKK complex contains two kinase subunits, IKKα and IKK, and a 
noncatalytic regulatory subunit IKK (64, 179, 226, 291, 294). Once liberated from 
the inhibitors, NF-B transcription factors translocate into the nucleus. In the 
nucleus NF-κB binds to functional κB sites in the promoter regions of target genes 
and modulates the expression of several hundred target genes, including genes, 
which produce cytokines and chemokines, growth factors, pro- and antiapoptotic 
proteins, cell surface receptors, cell adhesion molecules, immunoreceptors and 
transcription factors (104, 105) (an extensive list can be found at: www.nf-kb.org). 
Since the activation of NF-B does not require de novo protein synthesis, some 
genes can be transcriptionally upregulated within minutes after the stimulation. 
 
NF-κB and IκB proteins 
NF-B transcription factors are dimers of polypeptides belonging to the Rel family 
of proteins (85). All of these proteins share an N-terminal 300 amino acids long 
highly conserved domain called the Rel homology domain (RHD). RHD was first 
recogniced in the transforming gene of the avian reticuloendotheliosis virus (35, 93). 
In mammals NF-B family of transcription factors is comprised of five members: 
p50, p52, p65 (RelA), c-Rel and RelB (85) (Figure 6). Mature NF-κB proteins are 
between 433 (p50) and 619 (c-Rel) amino acids in lenght. In contrast to p65, c-Rel 
and RelB, which are synthesized as mature proteins, p50 and p52 are first 
synthesized as large precursor molecules of 105 (p105) and 100 kDa (p100), 
respectively. Removal of the C-terminal halves of the precursors by the 
proteasome results in the formation of active p50 and p52 subunits (18, 71, 185).  
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Figure 6. Schematic representation of NF-κB and IκB proteins. The Rel homology 
domain (RHD) mediates dimerization between the subunits and makes 
specific contacts with the target DNA. Transactivation domains mediate the 
activation of transcription. The glycine-rich domains (GRR) of p105 and 
p100 are involved in proteolytic processing of the precursors to the mature 
p50 and p52 subunits. The arrows point to the proteolytic processing sites 
for p50 and p52. Ankyrin domains (yellow) mediate the binding of IκBs to 
the RHDs of NF-κB proteins. For post-translational modifications see text 
for details.   
The RHD of NF-κB proteins can be further divided into two distinct motifs, which 
are connected with a flexible linker and present a β sheet Ig-like fold. The N-
terminal Ig-like motif within the RHD makes specific contacts with target DNA, and 
the C-terminal motif of RHD is exclusively responsible for dimer formation between 
the NF-κB subunits. The C-terminal motif within the RHD also forms binding site 
for IκB molecules and makes non-specific contacts with DNA (33). NLSs of NF-κB 
proteins are located at the very C-terminal end of the RHDs. RelB has an additional 
leuzine zipper (LZ) motif in its N-terminus preceeding the RHD, which is required 
for transcriptional activation by RelB. The glycine-rich regions (GRR) next to RHDs 
of p105 and p100 are required for efficient processing of the precursors to p50 and 
p52. Active, DNA-binding form of NF-κB is a dimer. The ubiquitously expressed 
p50/p65 dimer is the most abundant form of NF-B encountered in most cells, but 
all members of the family can associate to form homodimers or heterodimers exept 
for RelB, which can only form heterodimers in vivo (34, 50, 67, 105, 113, 166, 228, 
278). It has been proposed that the LZ domain of RelB may contribute to the 
instability of RelB homodimers in vivo (113). p65, c-Rel and RelB proteins share a 
carboxy-terminal TAD, which strongly activates transcription and allows them to 
form transcription activating dimers with each other and with p50 and p52. 
However, p65/RelB dimers are considered inhibitory since they cannot bind to any 
tested B sites indicating that p65/RelB heterodimers are unable to bind DNA (166). 
p50 and p52 lack TADs and can therefore activate transcription only upon 
heterodimerization with p65, c-Rel or RelB. Homodimers of p50 and p52 function 
as transcriptional repressors, but can activate transcription when bound to 
predominantly nuclear IB protein Bcl3 (25, 79). The crystal structures of several 
NF-B dimers have been described, including those bound to DNA or complexed 
with IB (34, 50, 83, 112, 113, 116, 119, 162, 189).   
NF-κB proteins undergo a variety of post-translational modifications to achieve full 
biological activity. Of the NF-κB proteins, the major target for post-translational 
modifications described is p65. Acetylation plays a significant role in regulating the 
nuclear activity of p65 containing dimers. p65 is acetylated at multiple lysine 
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residues, and the acetylation of each of these lysines appears to regulate different 
biological properties. Acetylation of lysine 310 stimulates transcription, whereas 
acetylation of lysines 122 and 123 has an inhibitory effect (36, 131). Acetylation of 
lysines 218 and 221 inhibits p65 binding to nuclear IκBα and thus, enhances the 
duration of NF-κB activation. This also links the acetylation to nuclear localization 
of NF-κB since deacetylation of lysine 221 promotes IκBα binding and leads to 
rapid nuclear export of p65 containing NF-κB dimers (36).  
Phosphorylation of p65 at various locations, including serines 205, 276, 281, 311, 
468 and 529, has been shown to be important in the initiation of transcription (208, 
282). It has been demonstrated that a part of p65 pool is constitutively 
phosphorylated at serine 536 (29, 171, 231). In nuclear translocation of p65, the 
phosphorylation at serine 536 seems to have an interesting role by defining an IκBα-
independent NF-κB pathway (231). Serine 536 phosphorylated p65 was not 
associated with IκBα or p50 and chemical inhibition of the proteasome reduced the 
nuclear translocation of total p65 but not that of serine 536 phosphorylated p65 (29, 
171, 231). Furthermore, a dominant negative IκBα mutant did not suppress the 
serine 536 phosphorylated p65 transcriptional activity. These findings indicate that 
nuclear localization of p65 phosphorylated on serine 536 is not regulated by IκBα. 
In response to TNF-α stimulation p65 is phosphorylated at threonine 254 (227). This 
induces the binding of p65 to peptidyl-prolyl isomerase Pin-1, which in turn, 
disrupts the interaction of p65 with IκBα and induces the nuclear translocation of 
p65 containing NF-κB dimers (227). In the nucleus phosphorylation at threonine 
505 within the p65 TAD inhibits p65 mediated transcription (224).      
Other NF-κB proteins are also targets for post-translational modifications. It has 
been shown that IKKε phosphorylates c-Rel, a modification that induces its nuclear 
translocation due to the dissociation of IκBα/c-Rel complexes, however the 
phosphorylation sites were not determined (96). Serine 266 phosphorylation 
mediated by PKA has also been suggested to induce the nuclear localization of c-Rel 
(187). Serine 471 phosphorylation of c-Rel seems to be required for TNF-α-
mediated activation (167). In addition, c-Rel has been shown to undergo proteolytic 
processing upon ubiquitination by a mechanism similar to the inducible degradation 
of IκB proteins (32). Phosphorylation of p50 at serine 337 has reported to enhance 
its binding to DNA (111). RelB has been shown to be phosphorylated at two serine 
and one threonine residues: serine 386 phosphorylation induces RelB dimerization 
with p100 and inhibits its processing to p52 and phosphorylations of threonine 84 
and serine 552 lead to inducible degradation of RelB in T cells in a fashion similar 
to IκBs (160, 165).  
The majority of p50 is generated by constitutive co-translational processing of the 
precursor p105. This generates the basal pool of inhibitory p50/p50 homodimers 
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bound to κB sites under unstimulated cellular conditions. Rel homology domain of 
p105 can undergo co-translational dimerization (152). While required for efficient 
p50 production, the coupling of co-translational processing and dimerization 
uniquely generates p50/p105 heterodimers (152). p105 can also be degraded by 
stimulus specific manner (46, 141). This involves the phosphorylation of p105 at C-
terminal serine residues 927 and 932 by IKKβ and leads to the ubiquitination of 
p105 at multiple lysines and complete degradation of p105 without generation of 
p50. IKKβ can also mediate the inducible processing of p105 to p50, a process 
which is poorly understood mechanistically. In this process, glycine-rich region of 
p105 at amino acids 376-404 functions as processing stop signal for the proteasome 
(153). This inducible processing involves C-terminal phosphorylation of p105, and 
probably ubiquitination at single lysine residue similar to the inducible processing of 
p100 (45, 46). In resting cells, p105 can also be phosphorylated by glycogen 
synthase kinase-3 β at serine residues 903 and 907. This stabilizes p105 under 
resting conditions, but is required for TNF-α stimulation mediated inducible 
processing of p105 (61).  
In contrast to p105, p100 is not constitutively processed to generate p52 under 
normal cellular conditions. Inducible processing of p100 involves the activation of 
NF-κB inducing kinase (NIK) and IKKα and leads to the phosphorylation of p100 at 
its N-terminal serine residues 99, 108, 115 and 123 and C-terminal serine residues 
866, 870 and 872 (288). Phosphorylation of p100 at these sites leads to the 
ubiquitination of p100 at lysine 856 and subsequent degradation of the C-terminal 
half of p100, and activation of p52 containing (mostly p52/RelB) NF-κB dimers (58, 
208, 288). The glycine-rich region at amino acids 346-377 inhibits the complete 
degradation of p100 (103). The N-terminal serine phosphorylation may also play a 
role in the dimerization functions of p100 with NF-κB subunits (213). Constitutive 
processing of p100 has been observed in leukemic T cells and in various lymphomas 
associated with nfκb2 (p100 producing) gene  rearrangements (257, 287).   
The activity of NF-B is tightly regulated by its association with IB proteins, a 
subfamily of the large ankyrin repeat domain (ARD) containing protein superfamily 
(7, 145, 183, 244) (Figure 6). IκB proteins contain six or seven ARDs that 
mediate the binding of IκBs to the RHDs of the NF-κB proteins, preventing their 
nuclear translocation and DNA binding (98, 99). IB proteins found in humans 
include IBα, IB, IB, IB (C-terminal half of p105), IB (C-terminal half of 
p100), Bcl3 and recently described IκB	 (154, 197, 265, 279, 280, 293). The 
classical IB proteins, IBα, IB and IB, are preferentially localized in the 
cytoplasm, where they bind to NF-B dimers masking one or both NLSs on the 
dimer (15, 154, 161, 162, 279, 293). The C-terminal regions of p105 and p100 
contain seven ARDs and function as autoinhibitory IB domains to retain p105 and 
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p100 containing NF-κB dimers in the cytoplasm (191, 192, 223). In addition, p100 
can form trimeric complexes with p50/p65 or p50/RelB dimers, but the function of 
these complexes has remained uncharacterized (59, 62, 127). In contrast to other IκB 
proteins, Bcl3 and IκB	 are not degraded upon stimulation of NF-B activating 
pathways. The predominantly nuclear Bcl3 and IκB	 proteins regulate the nuclear 
NF-B activity rather than its translocation from the cytoplasm into the nucleus. 
Bcl3 associates specifically with the inhibitory p50/p50 and p52/p52 homodimers in 
the nucleus, and in contrast to the classical IκB proteins, this association with Bcl3 
leads to an increased transcriptional activity (25, 76, 77); Bcl3 can induce the 
p50/p50 homodimers to dissociate from the κB site providing space for the trans-
activating NF-κB dimers containing p65, c-rel or RelB, or it can directly activate 
transcription by forming a trimeric complex with DNA-bound p50/p50 or p52/p52 
homodimers (25). The recently described IB	 stably accumulates in the nucleus 
where it associates with p50 and p65 and, opposite to the function of Bcl3, inhibits 
the NF-B activity (265).  
All the major cytoplasmic IκBs, IκBα, IκBβ and IκBε, have a conserved motif in 
their N-terminal end, which contains two serine residues that become 
phosphorylated by IKKβ upon activation of the IKK complex. Phosphorylation 
leads to the ubiquitination of the nearby lysine residues, and subsequent degradation 
of the inhibitors from the IκB/NF-κB complexes (208, 232). Once ubiquitinated, 
IκBα is degraded very rapidly, whereas the activation of IκBβ and IκBε containing 
NF-κB complexes occurs more slowly. Altough IκBα and IκBβ bind preferentially 
to p65 and c-Rel containing NF-κB dimers they posses functional differences in 
vivo. The activation of NF-κB by IκBα degradation is rapid but transient, whereas 
IκBβ degradation leads to more persistent NF-κB activation in a cell type and 
stimulus specific manner (264, 267). This functional difference can be explained by 
the fact that activation of NF-κB rapidly upregulates the expression of its inhibitor 
IκBα but not IκBβ (267). Moreover, the newly sythesized IκBα rapidly enters the 
nucleus where it can cause the dissociaton of NF-κB dimers from DNA (267).  
In response to ultraviolet light treatment or certain oncogenes, IKKβ-independent 
phosphorylation of IκBα has been reported (225). IKKβ-independent 
phosphorylation occurs to the C-terminal end of IκBα and it is mediated by casein 
kinase II (CK2)-dependent pathway. C-terminal phosphorylation leads to 
degradation of IκBα, but the mechanism is independent of the proteasome and 
poorly characterized. C-terminal end of IκBβ can also be phosphorylated by CK2 
leading to a loss of IκBβ mediated NF-κB inhibition (43).  
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Two NF-κB pathways 
NF-B is activated through two main signalling pathways: the classical pathway and 
the alternative pathway (Figure 7). These two pathways have distinct regulatory 
functions: the classical pathway is mostly involved in innate immunity and the 
alternative pathway in adaptive immunity (17, 24, 100). The classical pathway 
mostly targets p50/p65 and p50/c-Rel dimers maintained in the cytoplasm by IB 
proteins. The classical pathway is triggered by pro-inflammatory cytokines, such as 
TNF-α and IL-1, as well as by microbial products. Toll-like receptors (TLRs) 
recognice diverse microbial products, collectively known as pathogen-associated 
molecular patterns (PAMPs). Ten different TLRs have been found in human cells, 
and despite the diversity of the TLRs, stimulation of all TLRs lead to the activation 
of NF-B (68, 174). Upon activation by PAMPs, a TLR triggers a signalling 
cascade, culminating in the eventual activation of NF-B, which binds to the 
promoter regions of genes that produce inflammatory cytokines such as TNF-α, IL-1 
and IL-2 (68). The release of these cytokines and cytokines such as IFN- is the 
characteristic feature of the cellular response to the activation of the innate immune 
system (17, 24, 100).  
The classical pathway signals to NF-B by activating the IKK complex. IKK 
complex is activated through lysine 63-linked ubiquitination of the regulatory 
subunit IKK (39, 126). Lysine 63-linked ubiquitination, in contrast to lysine 48-
linked, does not lead to proteasomal degradation, but instead, is mostly involved in 
protein targeting (273). Ubiquitination of IKK is required for the activation of 
IKK. Activated IKK, in turn, phosphorylates IBα, IκBβ and IκBε at two N-
terminal serine residues leading to their lysine 48-linked polyubiquitination and 
subsequent proteosomal degradation (128). The IKKα subunit of the IKK complex 
is dispensable for the activation of the classical pathway (232).  
The alternative pathway is activated by a more limited number of stimuli and 
functions mainly in response to stimulation of a subset of the TNF-receptor 
subfamily, including receptors for lymphotoxin-, B cell-activating factor (BAFF) 
and CD40 ligand (44, 58, 60, 130). Stimulation of these receptors leads to the 
activation of NIK. NIK selectively phosphorylates IKKα/IKKα homodimers, 
essential for the activation of the alternative pathway (288). The activation by NIK 
and IKKα (not requiring IKK or IKK) leads to the N- and C-terminal 
phosphorylation of p100, ubiquitination of p100 at lysine 856 and subsequent 
proteasomal degradation of the C-terminal half of p100 (58, 208, 213, 288). As p100 
is most commonly associated with RelB, activation of the alternative pathway 
mostly results in nuclear translocation of p52/RelB dimers. The products of the 
genes activated by the alternative NF-κB dimers are mainly involved in the 
development and the maintenance of secondary lymphoid organs (58).  
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Figure 7. NF-κB signaling pathways. Upon receptor stimulation, the classical NF-κB 
pathway (left) activates the inhibitory κB kinase (IKK) complex. IκBs are 
degraded upon IKKβ-mediated phosphorylation and subsequent 
ubiquitination. The activation of the alternative NF-κB pathway (right) 
leads to the actvation of IKKα homodimers via an upstream NF-κB-
inducing kinase (NIK). p100 is processed to p52 in response to 
phosphorylation by IKKα. The dashed lines represent the “hybrid” pathway 
(see text for details). Liberated NF-κB dimers translocate into the nucleus, 
where they bind to the promoter regions of NF-κB responsive genes. The 
classical pathway is activated within minutes, whereas the activation of the 
alternative pathway can take a few hours. 
In the alternative pathway, p100 can also be dimerized with p65 or c-Rel. 
Degradation of the C-terminal part of p100 from these dimers generates p52/p65 and 
p52/c-Rel heterodimers. These dimers can then enter the nucleus or, alternatively, 
bind to other IB molecules (RelB containing dimers are not well bound by the 
classical IB proteins (247)). After stimulation of the classical NF-B pathway and 
phoshorylation via the classical IKK complex, these IBs are degraded releasing the 
active p52/p65 or p52/c-Rel heterodimers. This pathway is at the crossroads of the 
classical and the alternative pathways, and has sometimes been called as the 
“hybrid” pathway (58). The classical and the alternative NF-B pathways are further 
linked, since the inducers of the alternative pathway also stimulate the classical 
pathway and the activation of the classical pathway drives the expression of p100 
and RelB (24, 27, 58). While the classical pathway is activated within minutes, the 
activation of the alternative pathway can take a few hours.  
 
Nucleocytoplasmic transport 
p50, p65, p52 and c-Rel proteins have been shown to contain monopartite NLSs, 
which mediate the nuclear import of the proteins (22, 30, 81, 143, 149). NLS of 
RelB has remained uncharacterized. Once in the nucleus, NF-κB induces the 
expression of its own inhibitor IκBα (and to a lesser extent IκBε) but not IκBβ (41, 
256, 261, 265, 267). The newly synthetized IκBα rapidly enters the nucleus, where 
it binds to NF-κB dimers on the promoters of NF-κB responsive genes and inhibits 
NF-κB-mediated transcription (293). This provides a negative feedback loop for the 
rapid activation determined by IκBα degradation. IκBα has been shown to contain 
an unconventional NLS, but no importins have so far been shown to be involved in 
the nuclear import of IκBα (230). The nuclear import of IκBα has been proposed to 
be mediated by additional NLS-containing proteins, or by direct contacts with the 
proteins of the NPC (229, 269). In addition, IκBα has been shown to contain two 
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strong NESs, one in its C-terminus and other in its N-terminus (5, 114, 115, 123). 
IκBα nuclear export is mediated via the Crm1 pathway (5, 115). Free IκBα can 
continuously shuttle between the nucleus and the cytoplasm by the means of its NLS 
and NESs. Both NESs, together with the NLS of IκBα, function in postinduction 
repression of NF-κB by mediating the nuclear export of IκBα/NF-κB complexes. 
The NLS of IκB is masked when the protein is bound to NF-κB dimers. IκBε has 
been shown to contain leucine-rich NES and the nuclear export of IκBε is mediated 
by Crm1 (146). Furthermore, like IκBα, also IκBε can regulate the nuclear export of 
certain NF-κB dimers (146). 
No NLSs have been described in other IκB proteins. However, it has been shown 
that IκBβ can enter the nucleus when not bound to NF-κB dimers (259, 274). The 
mechanism of IκBβ nuclear import has not been determined. In the nucleus IκBβ 
can sustain the transcriptionally active NF-κB complex by binding to p50/p65 
dimers, and thus preventing the binding and subsequent postinduction repression by 
IκBα (11). 
Several reports suggest that NF-κB/IκBα complexes shuttle continuously between 
the nucleus and the cytoplasm in uninduced cells (114, 123, 260). It has been shown 
that in the IκBα/p50/p65 complexes, IκBα masks only the NLS of p65 protein 
(161). The shuttling of the IκBα/p50/p65 complex is proposed to be mediated by 
p50 NLS, which remains accessible in the complex. In contrast to IκBα containing 
complexes, IκBβ/NF-κB, IκBε/NF-κB or IκB/NF-κB complexes remain 
exclusively in the cytoplasm in unstimulated cells (84, 115, 161, 184, 261). It has 
been proposed that the cytoplasmic retention of these complexes could involve 
additional factors that mask their exposed NLSs (38, 184), or that the free NLS in 
the IκBα regulated complex is more accessible than the IκB contact free NLSs in 
the complexes regulated by other IκB molecules (261, 262). However, another 
report proposes a different model for the nucleocytoplasmic shuttling of IκBα/NF-
κB complexes (30). In that model the shuttling is suggested to be a consequence of 
inhibitor dissociation followed by separate nuclear import of the subunits rather than 
the complex as a whole.  
p65 possesses a strong NES, which efficiently mediates the nuclear export of p65 
even in the absence of IκBα (95). However, overexpressed p50/p65 complexes 
efficiently localize into the nucleus, indicating that when bound to p50, the NES of 
p65 is masked and cannot interact with Crm1. The nuclear export of p50/p65 
complexes is proposed to be mediated by IκBα (260). No NESs has been described 
in p50, p52, RelB or c-Rel proteins.   
It has been demonstrated that the cellular localization of RelB is regulated by p100 
and not by IκB proteins (247). It was further proposed that RelB/p100 complexes 
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shuttle in and out of the nucleus, and that the shuttling is mediated by one or more 
putative NESs present between amino acids 744 and 900 of p100. The possible 
nuclear import mechanisms of RelB/p100 complexes were not discussed. 
In conclusion, the control of NF-κB activity by nucleocytoplasmic shuttling of NF-
κB and IκB proteins is a multi-phased and highly regulated process. Furthermore, 
most likely additional interactions between distinct IκB and NF-κB proteins, as well 
as additional mechanisms and molecules involved in the regulation of nuclear 
import and export of IκB molecules and IκB/NFκB complexes still remains to be 
discovered.  
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3 AIMS OF THE STUDY 
Control of nuclear localization is a key mechanism in regulating the activity of many 
transcription factors. The principal aim of this stydy was to analyze the nuclear 
import mechanisms of STAT1, STAT2 and NF-κB proteins.  
The specific aims of this study were: 
1. To analyze the possible interactions of STAT1 homodimers and 
STAT1/STAT2 heterodimers with importin α molecules (I, II) 
2. To determine the binding sites of importin α molecules for STAT1 and 
STAT2 proteins (II) 
3. To analyze the possible interactions of NF-κB proteins with importin α 
molecules (III, IV) 
4. To analyze the functionality of the NLSs of the individual NF-κB subunits 
in the importin α interactions and in the nuclear import of different NF-κB 
dimers (III, IV) 
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4 MATERIALS AND METHODS 
4.1 Cell culture (I-IV) 
Human lung carcinoma A549 (ATCC, CCL 185), human larynx carcinoma Hep-2C 
(ATCC, CCL 23) and human hepatocellular carcinoma Huh7 (190) cell lines were 
maintained in Eagle-MEM (Sigma) supplemented with antibiotics, glutamine and 
10% fetal calf serum (FCS; Integro). Human NK-92 (ATCC, CLR 2407) cell line 
was maintained in MEM alpha medium (Sigma) supplemented with 0.2 mM i-
inositol, 20 mM folic acid, 40 mM 2-ME, antibiotics, glutamine, 100 IU/ml rIL-2, 
12% FCS and 12% horse serum (Invitrogen). Monolayers and suspension cultures of 
Spodoptera frugiperda (Sf9) insect cells that were used for baculovirus expression 
were maintained in TNM-FH medium as described by Summers and Smith (255).   
4.2 DNA manipulation (I-IV) 
Expression vectors pGEX-2T and pETM-30 were used for producing GST-fusion 
proteins in Esterichia coli (E. coli). pcDNA3.1(+) (Invitrogen), FLAG-
pcDNA3.1(+) (175) and pcDNA3.1-Myc-his(-) (Invitrogen) expression vectrors 
were used for in vitro translation and transient transfection of cultured cells. The 
plasmid pAcYM1 (255) was used for producing recombinant baculoviruses.  
cDNAs to be cloned into the expression vectors were first modified by PCR to 
create N- and C-terminal BamHI, BclI or BglII sites for further cloning into the 
BamHI site of pGEX-2T,  pcDNA3.1(+), FLAG-pcDNA3.1(+), pcDNA3.1-Myc-
his(-) or pAcYM1 vectors or to create N-terminal NcoI and C-terminal XhoI sites for 
cloning into pETM-30 vector. To create a GST fusion vector for baculovirus 
expression system GST-encoding cDNA was first modified by PCR using the 
pGEX-2T fusion vector as a template. The PCR product was subcloned into the 
pAcYM1 baculovirus expression vector. Point mutations to genes were done 
directly to the genes in the expression vectrors using the QuickChangeTM site-
directed mutagenesis kit (Stratagene). All DNA manipulations were performed 
according to standard protocols.   
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4.3 Protein expression and analysis 
4.3.1 Production of GST-fusion proteins in E. coli cells (I-IV) 
Proteins were expressed in E. coli BL-21 StarTM (DE3) cells as GST fusion proteins 
under 0.2 – 1.0 mM IPTG induction at 21 °C for 4 – 24h. Bacteria were lysed in 50 
mM Tris-HCl buffer, pH 7.4, 150 mM NaCl, 5 mM EDTA and 1% Triton X-100 
(lysis buffer) with 5 mg/ml lysozyme (Sigma) and protease inhibitors (Complete, 
Roche Applied Science) at room temperature for 15 – 30 min. Lysates were briefly 
sonicated and clarified by Eppendorf centrifugation (13 000 rpm, at 4°C, 10 min). 
4.3.2 Baculovirus expression (I-IV) 
For protein expression, Sf9 cells were infected with protein expressing baculoviruses 
for 42 h. Sf9 cells were collected, and whole cell extracts were prepared by 
disrupting the cells in lysis buffer on ice for 10 min. The cells were further disrupted 
by passing them through a syringe. Lysates were clarified by Eppendorf 
centrifugation (13 000 rpm, at 4°C, 10 min).  
4.3.3 Western blotting (I-IV) 
Cleared whole cell lysates (10 – 30 μg) or proteins in the samples from a particular 
experiment were separated by SDS-PAGE using the Laemmli buffer system. The 
proteins were transferred electrophoretically onto Immobilon-P membranes.  
Membranes were stained with antibodies in PBS + 0.05% Tween-20 containing 5% 
non-fat milk for 1 h at room temperature. Proteins were visualized by enhanced 
chemiluminescence system (Amersham Biosciences). Detailed information about 
the antibodies used can be found in the original publications. 
4.3.4 Gel filtration and protein oligomerization analysis (I)      
E. coli or baculovirus-infected Sf9 cell lysates were gel filtrated in lysis buffer using 
24 ml Superose 12 fast protein liquid cromatography (FPLC) gel filtration column 
(Amersham Biosciences). To study STAT-importin α5 complex formation STAT 
and GST-importin α5 protein-containing cell extracts were mixed and gel filtrated. 
The proteins in the gel filtration fractions were separated by SDS-PAGE followed 
by Western blotting and staining with anti-GST, anti-STAT1, anti-phospho-STAT1 
and anti phosphotyrosine antibodies. To estimate the relative amounts of STAT and 
importin α5 proteins in STAT1/STAT2-importin α5 complexes, the proteins in the 
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gel filtration fractions were separated by SDS-PAGE followed by Coomassie blue 
staining. The quantitation of protein bands was performed with the Kodak 
electrophoresis documentation and analysis system 120.    
4.3.5 GST-importin/fusion protein binding assay (I-IV) 
For GST pull-down experiments, GST fusion proteins from E. coli or Sf9 cell 
extracts were first allowed to bind to 25 μl of glutathione-Sepharose 4 Fast Flow 
beads (Amersham Biosciences) at 4 °C for 1 h in lysis buffer in slow rotation 
followed by washing three times with the buffer. 25 μl of glutathine-Sepharose-
immobilized GST fusion protein was mixed with 0.1 – 1.2 ml of cell lysate and 
rotated at 4 °C for 2 h followed by washing three times with lysis buffer. Proteins in 
the samples were dissolved in 50 μl of 2X Laemmli sample buffer and separated by 
SDS-PAGE. The gels were stained with Coomassie blue or Western blotted and 
stained with antibodies.  
4.4 Protein-DNA interaction studies  
4.4.1 Oligonucleotide DNA precipitation (III) 
Cleared A549 whole cell lysates from TNF-α-stimulated cells or control cells were 
allowed to bind to 5’-biotinylated CCL5 or CXCL10 promoter NF-κB 
oligonucleotides. The complexes were separated by streptavidine-agarose beads, and 
the oligonucleotide bound proteins were separated on SDS-PAGE and analyzed by 
Western blotting with anti-p65 and anti-p50 antibodies.  
4.5 Indirect immunofluoresence and confocal laser microscopy (I, 
III, IV) 
For confocal laser microscopy transiently transfected or untrasfected HuH7 cells 
were grown on glass coverslips. Cells were left untreated or stimulated with human 
leucosyte IFN-α (100 IU/ml) or TNF-α (100 ng/ml). The cells were fixed and 
stained with antibodies. The antibody-stained proteins were visualized and 
photographed on a Leica TCS NT confocal laser microscope. 
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5 RESULTS AND DISCUSSION 
5.1 Nuclear import mechanisms of STAT1 homodimers and 
STAT1/STAT2 heterodimers (I, II) 
Prior to this thesis study, observations in our laboratory have demonstrated that 
STAT1 and STAT2 have a structural arginine/lysine-rich element involved in their 
IFN-induced nuclear import (177). This unusual structural NLS was shown to be 
situated in the DNA binding domain of the molecule and become active only in 
dimers. The amino acids critical for nuclear import were mapped to lysines 410 and 
413 of STAT1 and arginine 409 and lysine 415 of STAT2 (177). A few years before 
the unconventional dimer-specific NLSs were described, the mechanism regulating 
the nuclear localization of STAT1 was proposed to involve the function of importin 
α5 molecule (238). In that report, the authors showed that tyrosine-phosphorylation 
and homodimerization of STAT1 are essential for the interaction with importin α5. 
At that time, these two publications were the only reports describing NLSs or 
importin α interactions of STAT proteins.  
5.1.1 STAT activation using baculovirus expression system 
The critical event in cytokine-dependent STAT-mediated transcriptional regulation 
is phosphorylation of STATs on a single tyrosine residue at their C-terminus (54, 
243). In response to an activating cytokine, such as IFNs, STAT1 homodimers or 
STAT1/STAT2 heterodimers are activated mostly by receptor accosiated Jak1/Jak2 
or Jak1/Tyk2 kinases, respectively. However, the specificity of Jaks relies on their 
capacity to associate with particular cytokine receptor subunit rather than because of 
a high degree of intrinsic substrate specificity. In our experimental setting, 
coinfection of Sf9 cells with Tyk2 baculovirus construct and STAT1, STAT2 or 
STAT1-NLS- (K410A, K413A) protein expressing baculoviruses resulted in 
efficient tyrosine-phosphorylation of the STAT proteins (I, Figure 1). When 
expressed with Tyk2, Y701A mutant of STAT1 completely lacked tyrosine-
phosphorylation required for formation of the active dimer. STAT2 does not form 
active tyrosine-phosphorylated homodimers. Tyrosine-phosphorylated STAT1 or 
STAT1-NLS- formed homodimers, and when expressed with STAT2, tyrosine-
phosphorylated heterodimers of STAT1/STAT2 or STAT1-NLS-/STAT2 were 
obtained (I, Figures 1 and 6). This enabled us to examine potential interactions 
between dimeric STAT complexes and importins with GST-importin protein 
binding assay. 
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5.1.2 Activated STAT1 homodimers and STAT1/STAT2 heterodimers 
directly bind to importin α5 via an unconventional structural 
NLS. 
Since IFN-induced nuclear import of STAT1 had been suggested to be mediated by 
importin α5, and since it had been demonstrated that STAT1 and STAT2 proteins 
have a well conserved, unusual arginine/lysine-rich NLS, which regulates their 
nuclear import (177), we wanted to study whether this NLS element would be 
involved in direct binding of STATs to importin α molecules (I).  
To determine the possible interactions of STAT1 homodimers and STAT1/STAT2 
heterodimers with importin α5, pull-down assays were performed with GST-
importin α5 fusion protein produced in E. coli and STAT dimers activated in the 
baculovirus expression system. We observed that wild type (wt) STAT homodimers 
and STAT1/STAT2 heterodimers bound strongly to importin α5 molecule (I, Figure 
2). Instead, homodimers of STAT1-NLS- or STAT1-NLS-/STAT2 heterodimers 
completely failed to bind to importin α5. Also monomeric STAT1 Y701A mutant 
and tyrosine phosphorylated wt STAT2 were devoid of importin α5 binding. The 
importin α5-STAT complexes were relatively stable, since washing with 2M NaCl 
or 2M urea did not disrupt the preformed importin α5-STAT interaction (I, Figure 
3). After the observations from the GST-pull down experiments, the effects of 
STAT1 and STAT2 NLS mutants were studied in cultured HuH7 cells. When the 
cells were transfected with wt STAT1 and STAT2-NLS- (R409A, K415A) or with 
wt STAT2 and STAT1-NLS-, we found that, both transfected proteins colocalized 
exclusively in the cell cytoplasm (I, Figure 4). Furthermore, when we transfected the 
cells with importin α5 and wt or NLS mutant forms of STAT1 or STAT2, we 
observed that, in contrast to wt molecules, no colocalization of importin α5 with 
STAT1 or STAT2 NLS mutants was found (I, Figure 5). These results indicate that 
STAT1 homodimers and STAT1/STAT2 heterodimers bind to importin α5 via 
unconventional NLSs that become active only in dimers.  
At the same time, an article demonstrating direct interaction of tyrosine-
phosphorylated STAT1 homodimer with importin α5 was published (172). In that 
study the authors characterized a STAT1 L407A mutant, which forms tyrosine-
phosphorylated homodimers and binds to DNA but does not bind to importin α5. 
The authors further proposed that NLS exists in an inactive state within a STAT1 
monomer and becomes active upon dimerization. In addition, based on studies with 
the STAT1 L407A mutant in transfected cells, the authors suggested that an intact 
NLS in one STAT1 molecule is sufficient to translocate STAT1 homodimers or 
STAT1/STAT2 heterodimers into the nucleus. However, our results clearly showed 
that when STAT1 (K410A, K413A) NLS mutant was dimerized with wt STAT2 and 
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the dimer was tyrosine-phosphorylated, the complex did not show any binding to 
importin α5, nor was it transported into the nucleus in transfected cells (I, Figures 1, 
2 and 4). Furthermore, when wt STAT1 was transfected with STAT2 (R409A, 
K415A) NLS mutant, both proteins colocalized exclusively in the cell cytoplasm (I, 
Figure 4). These results clearly indicate that two of these arginine/lysine-rich 
elements, one in each monomer, that form the conformational NLS of a STAT 
dimer, are required for recognition by importin α5 and subsequent nuclear import to 
take place. However, there is a possibility that when STAT1 L407A mutant is 
homodimerized, the two amino acid substitutions in the dimer are sufficient to alter 
the conformation of the dimer-specific NLS (presumably composed of L407 in 
addition to K410 and K413 in each STAT1 monomer) enough to retain the complex 
in the cytoplasm. But, when the L407A mutant of STAT1 is dimerized with wt 
STAT1 or wt STAT2, the single amino acid mutation does not have that effect, and 
the precence of the intact amino acids constructing the NLS are sufficient to retain 
the NLS recognizable by importin α5.  
The importance of lysines 410 and 413 in the nuclear import of tyrosine-
phosphorylated STAT1 has also been confirmed by another group (180). The 
authors found that the constitutive and IFN--induced nuclear import of STAT1 
proceed through independent pathways. In that report, Meyer and coworkers further 
suggested that the unconventional conformational NLS is not involved in the 
constitutive nuclear import of STAT1. Consistent with this observation, it has been 
suggested by another group that the constitutive import of latent STAT1 is 
independent of importin α/β and could be mediated by direct contacts with the 
proteins of the NPC (164). Meyer et al., however, confirmed that lysines 410 and 
413 are dispensable for STAT1 dimerization, yet they are critical for the nuclear 
import of the tyrosine-phosphorylated molecule, which is in line with our results. In 
addition, they found that two hydrophobic residues, leucines 407 and 409, are also 
important for nuclear accumulation of phosphorylated STAT1. However, no 
importin α-STAT interactions were analyzed. Arginines 414 and 417 of STAT3, 
coresponding to lysines 410 and 413 of STAT1, have been shown to mediate the 
nuclear import of STAT3 (157). In addition, leucine 411 of STAT3, corresponding 
to leucine 407 of STAT1, was not essential for STAT3 nuclear transport in that 
study. This further supports the concept that lysines 410 and 413 in STAT1 play an 
important role in the nuclear import of STAT1. However, it is notable that STAT3 
nuclear import is likely to be mechanistically different from that of STAT1, since a 
region in the coiled coil domain of STAT3 with arginines 214 and 215 has been 
shown to mediate the importin α interaction and nuclear localization of STAT3 
(156, 157). Furthermore, mutation of arginine 210 and lysine 211 of STAT1, 
corresponding to arginines 214 and 215 of STAT3, did not have any effect on the 
IFN--induced nuclear import of STAT1 (157).   
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We also wanted to examine the possible interactions of endogenous, as well as 
baculovirus-produced STAT1/STAT2 dimers with other importin α isoforms in 
addition to importin α5 (II). Pull-down assays were performed with GST-importin 
α1, α3, α5 and α7 fusion proteins produced in E. coli and IFN-α-stimulated NK-92 
cell lysates or STAT1 homodimers or STAT1/STAT2 heterodimers activated with 
baculovirus expression system. Endogenous and baculovirus-activated STAT1 and 
STAT2 bound effectively to GST-immobilized importin α5, whereas no binding to 
importin α1, α3 or α7 was observed (II, Figures 2 and 3). This further confirmed the 
specific interaction of STAT1 and STAT2 with importin α5.  
NLSs have also been described to exist in some secreted cytokines, like IFN- (253). It 
has also been proposed that, after endocytosis with the receptor subunit, IFN- forms a 
trimeric complex with STAT1 and importin α5, and that the nuclear import of this 
complex is mediated by the IFN- NLS (252). However, this most likely is not the 
nuclear import mechanism for STAT1, since STAT1 NLS mutants, which form 
tyrosine phosphorylated dimers, do not localize into the nucleus (I) (172, 177, 180).  
5.1.3 STAT-importin α5 complexes consist of two STAT and two 
importin α5 molecules. 
To determine the protein composition of importin α-STAT complex, we examined 
the preformed importin α5-STAT complex by FPLC. We analyzed the fraction 
corresponding to the major peak (at 300-350 kDa) of importin α5-STAT1/STAT2 
complexes by SDS-PAGE. Based on the intensity of Coomassie-blue stained bands, 
it was possible to directly quantitate the STAT1, STAT2 and importin α5 protein-
specific bands. The protein levels indicated that in the complex, the relative amounts 
of STAT1 and STAT2 were equal, whereas the complex contained twice as much 
importin α5 (I, Figure 6). This suggests that the nuclear import complex of STATs 
is composed of two STAT molecules attached to two importin α5 molecules.  
5.1.4 STAT1 and STAT2 bind to the C-terminal Arm repeats 8 and 9 of 
importin α5. 
Previously, it has been suggested that the importin α5 binding site for STAT1 is distinct 
from the classical NLS binding site and is located at the very C-terminal end of importin 
α5 (238). By deletion analysis the binding site was located to the region between amino 
acids 475-538. However, the exact binding site was not determined (238).  
The classical NLS binding sites of importin α molecules are situated in regions, 
which consist of Arm repeats 2-4 (amino acids 118-245 of importin α5) and 7-8 
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(amino acids 331-412). These sites have been termed as the major and the minor 
NLS binding sites, respectively. The helical grooves of these sites contain the well 
conserved trypthophan and asparagine residues, which directly interact with the 
arginines and lysines of NLSs. It has been shown that the major binding pocket 
binds to the monopartite NLS and to the larger strech of basic residues in bipartite 
NLS, whereas the minor pocket interacts with the smaller strech of basic residues in 
bipartite NLS (47, 75). However, by using deletion analyses several molecules with 
classical and nonclassical NLS have been suggested to be able to bind to the C-
terminal regions of importin α1 and importin α5 molecules (72, 80, 90, 101).  
To determine the exact binding site of importin α5 for STAT1 and STAT2 we 
created mutations to the conserved trypthophan and asparagine residues in Arm 
repeats 2, 3, 4, 7, 8 and 9 of importin α5 molecule. We included Arm repeat 9 in our 
studies, because the two asparagine residues appeared as a part of a possible NLS 
binding pocket. In addition, different combinations of these Arm repeat mutations 
were constructed. By using GST-importin protein binding assay we found that 
mutations in Arm repeats 2, 3, 4, or 7 or different combinations of these had no 
effect on STAT1 or STAT2 binding to importin α5. Instead, the two amino acid 
mutations in Arm repeats 8 or 9 completely abolished the binding of STAT1 
homodimers and STAT1/STAT2 heterodimers to importin α5 molecule (II, Figure 
5). These results indicate that, instead of the very C-terminal end proposed 
previously (238), the exact binding site for STAT1 and STAT2 NLSs is the Arm 
repeat domains 8 and 9 of importin α5 molecule. This NLS binding site differs from 
the previously described minor NLS binding site composed of Arm repeats 7 and 8. 
Together with previous reports, this indicates that importin α molecules are flexible 
in using both, the N-terminal and the C-terminal, NLS binding pockets for binding 
to specific substrates.  
5.2 Nuclear import mechanisms of NF-κB proteins (III, IV) 
In mammals, NF-κB family of transcription factors comprises of five members: p50, 
p65, p52, RelB and c-Rel, which associate to form transcriptionally competent 
homo- and heterodimers. The most abundant and best characterized of these dimers 
is the prototypical NF-κB p50/p65 heterodimer. p50, p65, p52 and c-Rel have been 
shown to contain arginine/lysine-rich classical monopartite NLSs, which mediate the 
nuclear localization of the proteins (22, 88, 143, 149). However, prior to our studies 
there were no published data on the possible interactions of NF-κB proteins with 
importin molecules. In order to understand the molecular mechanisms of nuclear 
import of NF-κB, we studied the interactions of NF-κB with importins by pull-down 
assays and immunoprecipitation experiments.     
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5.2.1 NF-κB components of the classical and the alternative pathway are 
transported into the nucleus via a subset of importin α molecules  
In the beginning of this study (III), we had E. coli expression constructs for GST-
importin α1, α3, α5, α7 and β and baculovirus expression constructs for GST-
importin α1, α3, α4 and α7. Different expression systems were used, since at that 
time all isoforms could not be expressed in E. coli or by baculovirus expression 
system. First, with this limited set of GST-importins, we analyzed the interactions of 
the classical NF-κB pathway components p50 and p65 with importin molecules by 
GST-pull-down experiments. We found that endogenous p50 and p65, extracted 
from A549 cells, interacted specifically with importin α3 and α4 in a TNF-α 
stimulation-specific fashion (III, Figure 1AB). When we used GST-p50 and GST-
p65 fusion proteins in similar experiments, we found that GST-immobilized p50 and 
p65 bound importin α3 from A549 cell lysates (III, Figure 1D). The specific 
interaction was further confirmed by coprecipitating importin α3 with p50 and p65 
proteins from TNF-α-stimulated cell extracts using p50 or p65-specific antibodies 
(III, Figure 2). Consistent with endogenous proteins, also in vitro-translated p50 and 
p65 bound to GST-immobilized importin α3 (III, Figure 5). These data indicated 
that p50 and p65 are transported into the nucleus by importin α3 and importin α4.  
In the next set of experiments covering the nuclear import of NF-κB we had all 
different importin α isoforms as GST-fusion proteins (IV). Importin α6 was 
expressed in E. coli and other importin α isoforms in Sf9-cells (we were not able to 
produce functional importin α6 by baculovirus expression system). Using this full 
set of importin α molecules, we found that, consistent with our previous 
observations, endogenous p50 and p65 proteins bound to importin α3 and α4 in a 
stimulus specific fashion, while no binding to importin α1 or α7 was detected (IV, 
Figure 2). However, in this case we also observed that Sf9-expressed importin α5 
was able to bind p50 and p65 proteins, a result not obtained with E. coli-produced 
importin α5. Moreover, also importin α6 was found to interact with in vitro-
translated p50 and p65 (IV, Figure 1B). To further confirm the binding specificities 
of different importin α isoforms for p50 and p65 proteins, we performed 
immunoprecipitation experiments with Myc-tagged importin α constructs (all but 
α6), which were transfected in Huh7 cells. In coimmunoprecipitation analyses, 
importin α3 and α4 and to a lesser extent importin α5 readily bound p50 and p65 
from TNF-α-stimulated cell extracts (IV, Figure 3). These data together with the 
data above confirmed that importin α3 and α4 are mediating the nuclear import of 
p50 and p65 proteins. In addition, our results, obtained with the Sf9-produced GST-
importin α5 and with the transfected importin α constructs, revealed that also 
importin α5 is specifically involved in the nuclear import of p50 and p65. Since 
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importin α6 is expressed only in testis, it can be concluded that the primarily nuclear 
import of the classical NF-κB pathway components p50 and p65 is mediated via 
importin α3, importin α4 and importin α5.  
In addition to the data obtained with importin α5 here, we have recently observed 
that the nature of the expression system (prokaryotic vs. eukaryotic) can greatly 
affect the binding specificity of different importin α isoforms to the same cargo 
molecules (176). The differences in the binding specificities of E. coli- and Sf9-
expressed importin α isoforms suggest that post-translational modifications may be 
needed to alter the binding of some molecules to certain importin α molecules. It 
has, in fact, been demonstrated that the function of importin α1 can be regulated by 
phosphorylation and acetylation (272). The authors presented evidence that importin 
α1 contributes to the nuclear import of human mRNA binding protein HuR through 
two AMP-activating protein kinase (AMPK)-modulated mechanisms. First, AMPK 
was shown to trigger the acetylation of importin α1 at lysine 22, a process 
dependent on the activity of acetylase CBP/p300. Second, AMPK was shown to 
directly phosphorylate importin α1 at serine 105. The authors further demonstrated 
that importin α1 proteins bearing K22R or S105A mutations failed to mediate the 
nuclear import of HuR. Moreover, the authors observed that also importin α3 and 
α7 appear to be adequate in vitro-targets for AMPK-mediated phosphorylation. 
However, the significance of these modifications in the import functions was not 
dicussed. In addition, another report identified importin α1 and α7, but not importin 
α3, as substrates for CBP/p300 mediated acetylation (10). While it is known that the 
NLS-dependent nuclear import can be regulated by phosphorylation in the vicinity 
of the NLS (120-122), these findings indicate that the binding specificities of at least 
some importins can be regulated by phosphorylation and/or by acetylation. The lack 
of these regulation strategies could explain why we observed different binding 
specificities with bacteria-produced and Sf9-produced importin α5.  
To further analyze the nuclear import of NF-κB transcription factors, we studied the 
possible interactions of the alternative NF-κB pathway components p52, RelB and 
c-Rel with importin α molecules with similar pull-down experiments (IV). We 
found that in vitro-translated p52 (like p50 and p65 proteins) bound mainly to 
importin α3, α4, α5 and α6. In vitro-translated RelB and c-Rel, instead, bound to 
importin α5, α6 and α7 (IV, Figure 1B). When we analyzed the interaction of 
endogenous p52 to ubiquitously expressed importin α isoforms (that is all but α6), 
the result was consistent with the binding observed for in vitro-translated protein; 
importin α3, α4 and to a lesser extent α5 bound cellular p52 from Sendai virus-
infected or TNF-α-stimulated cell extracts (IV, Figure 2).  
Interestingly, the binding pattern of TNF-α-stimulated and Sendai virus infection-
induced endogenous RelB was clearly different from the in vitro-translated RelB. 
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Cellular RelB (like in vitro-translated protein) bound strongly to importin α5. In 
addition, cellular RelB also effectively bound to importin α4, whereas in vitro-
translated protein did not show any interaction with importin α4. Furthermore, in 
contrast to in vitro-translated protein, endogenous RelB did not show any binding to 
importin α7 (IV, Figures 1B and 2). This difference in the binding pattern of in 
vitro-translated and cellular RelB could be explained by the observation that RelB is 
the only NF-κB protein that does not form functional homodimers in vivo (113). Our 
data strongly suggest that when RelB is expressed in vitro, that is without other NF-
κB family members, the binding specificity of the protein to importin α molecules is 
different from the endogenous cellular RelB, which in its functional form exists only 
as heterodimers with other NF-κB proteins. These data also indicate that importin 
α3 and α4 are the likely candidates for the nuclear import of functional endogenous 
RelB containing dimers. Moreover, in contrast to p50, p52 and p65-containing NF-
κB dimers, it seems that importin α3 does not contribute significantly to the nuclear 
import of RelB-containing dimers. The data further suggest that importin α3 and α4, 
which are very closely related isoforms and comprise one importin α subfamily, can 
still have different substrate specificities for certain NF-κB family members. 
5.2.2 p50 binds to the N-terminal and p65 to the C-terminal NLS 
binding site of importin α3  
Since we had previously observed that importin α molecules are able to use either  
the N- or C-terminal NLS binding pockets for binding to different nuclear-targeted 
proteins (II), we wanted to analyze whether p50 and p65 would bind to the N-
terminal or C-terminal NLS binding sites of importin α3 (III).  
To locate the binding sites for p50 and p65 we performed pull-down assays with 
GST-importin α3 constructs bearing mutations in the N-terminal Arm repeat 3 or C-
terminal Arm repeats 7 and 8. Interestingly, we found that importin α3 uses different 
binding sites for binding p50 and p65 proteins. We found that mutations in Arm 
repeat 3 abolished the binding of p50 to importin α3 but had no effect on p65-
importin α3 interaction. In contrast, Arm repeats 7+8 mutation eliminated the 
binding of p65 to the importin but had no effect on p50 binding. Equal results were 
obtained with in vitro-translated and endogenous p50 and p65 proteins (III, Figure 
7). These results indicate that p50 and p65 are bound by different NLS binding sites 
of importin α3.  
This gave us a working model that one importin α3 molecule interacts with 
heterodimeric p50/p65 complex in a manner that the N-terminal NLS binding site 
interacts with p50 and the C-terminal binding site with p65. This interaction creates 
a stable transport complex with no space for IκBα. Biochemical experiments 
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supported this model, since increasing amounts of in vitro-translated IκBα competed 
with the interaction of p50/p65 complex for importin α3 (III, Figure 5B). 
Furthermore, when we studied the kinetics of TNF-α-induced p50/p65 activation 
and binding to importin α, we found that NF-κB binding to importin α3 was seen 
only after IκBα was degraded from the complex (III, Figure 3). Moreover, importin 
α3 coprecipitated with p50 and p65 proteins only after TNF-α stimulation, when the 
complex was free of IκBα (III, Figure 2). We propose that p50/p65 complex can, 
thus, bind to importin α3 only in the absence of IκBα. In addition, we did not 
observe any significant binding of cellular p105 or p100 to importin α molecules 
further indicating that NF-κB complexes containing the inhibitor IκBα do not bind 
to importin α molecules (III, Figure 3B; IV, Figures 2 and 4). 
The original model for NF-κB function postulated that in unstimulated cells the 
transcription factor is anchored in the cytoplasm by association with IκB molecules, 
which mask the NLSs of the subunits in the dimer (85). Later, the crystallocraphic 
structures of IκBα bound to p50/p65 dimers revealed that IκBα protein masks only 
the NLS of p65, whereas the p50 NLS remains accessible (116, 119). The precence 
of this accessible NLS on p50 coupled with NESs that are present on IκBα and p65 
was proposed to result in constant shuttling of IκBα/NF-κB complexes between the 
nucleus and the cytoplasm observed with in vivo immunofluorescence studies in 
unstimulated cells (114, 123, 260). Similarly, crystal structure of IκBβ/NF-κB p65 
homodimer complex showed that IκBβ contacts only one p65 NLS of the 
homodimer (162). In addition, it has been observed that in the IκB/NF-κB p50/p65 
heterodimeric complexes the p65 NLS is free from IκB contacts (184).  
However, based on several published reports, IκBα/NF-κB complexes are thought 
to shuttle continuously in and out of the nucleus, whereas IκBβ/NF-κB, IκBε/NF-
κB and IκB/NF-κB complexes remain constitutively cytoplasmic in resting cells 
(84, 114, 115, 123, 161, 260, 261). It has been proposed that the cytoplasmic 
retention of these complexes is regulated by additional proteins that mask their 
exposed NLSs (38, 184) or that the solvent exposed NLS is not just that accessible 
when the dimer is bound to IκBβ compared to the IκBα bound NF-κB dimer (261, 
262). However, whether the NLS is more or less accessible, our results clearly 
indicate that when NF-κB is bound to importin α molecules, the complex does not 
contain IκBα. Our results rather support the more recent reports, which propose a 
dissociation model, in where the constant shuttling of IκBα/NF-κB complexes 
observed in resting cells, is the result of inhibitor dissociation and separate nuclear 
import of IκBα and NF-κB rather than the complex as a whole (20, 30). However, 
our results do not rule out the possibility that IκBα/NF-κB complexes could enter 
the nucleus by the means of other than the classical importin α/β pathway. In fact, it 
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has been suggested that nuclear import of IκBα could be mediated by direct contacts 
with the components of the NPC (229).    
5.2.3 Identification of NLSs of NF-κB proteins regulating importin α 
interaction and nuclear import  
p50, p65, p52 and c-Rel proteins have been shown to contain arginine/lysine-rich 
NLSs that regulate their nuclear import. However, the possible NLS of RelB has 
remained uncharacterized. The amino acid sequence of RelB has two potential 
arginine/lysine-rich regions that could function as NLSs. These regions comprise 
amino acids 409-413 (KKRKR; NLS1) and 433-438 (KRRKKK; NLS2). To 
determine whether the previously identified NLSs of p50, p65, p52 and c-Rel and 
the potential NLSs of RelB mediate the interactions of these proteins with importin 
α molecules, we carried out binding experiments with GST-importins and in vitro-
translated wt or NLS mutant forms of NF-κB proteins. Details of the mutated amino 
acids are described in III and IV.  
We found that wt proteins bound effectively to the tested importin α molecules (eg. 
p50 and p65 to importin α3 and p52, c-Rel and RelB to importin α5), whereas NLS 
mutant forms of p50, p65, p52 and c-Rel as well as both NLS1 and NLS2 mutant 
forms of RelB failed to do so (III, Figure 6AB; IV, Figure 5). To confirm the results 
obtained in biochemical experiments also in cultured human cells, we analyzed the 
nuclear accumulation of wt and NLS defective proteins in transiently transfected 
HuH7 cells. We found that wt p50, p65, p52 and c-Rel proteins accumulated 
effectively in the nucleus, whereas the NLS mutants were localized in the cytoplasm 
(III, Figure 6C; IV, Figure 6AB). However, when the cells were transfected with 
RelB NLS1 or NLS2 mutant, the nuclear localization of RelB was somewhat 
impaired but still clearly detectable. Only after both of the potential NLS sequences 
were simultaneously mutated the nuclear import of RelB was eliminated (IV, Figure 
6C). These results show that the previously identified monopartite NLSs of p50, 
p65, p52 and c-Rel mediate the binding of these proteins to importin α molecules 
and regulate their nuclear import. Furthermore, the results presented here 
demonstrate that RelB, instead, has a bipartite NLS sequence, which mediates the 
binding of RelB to importin α molecules and regulates the nuclear import of the 
protein in transfected cells.  
 64 
5.2.4 Certain NF-κB family members are regulating the nuclear 
accumulation of a heterologous family member 
To further analyze the function of the NLS signals of NF-κB proteins in the nuclear 
import of specific dimers, we carried out cotransfection experiments with wt or NLS 
mutant forms of p50, p65, p52 and RelB proteins. The nuclear accumulation of the 
transfected proteins was studied with immunofluorescence microscopy (III, IV). 
When we compared the effects of transfected wt or NLS mutant form of p65 protein 
on the cellular localization of p50, we found that NLS defective p65 did not have 
any effect on the distribution of cellular p50 (III, Figure 8). This suggested that 
significant part of p50 homodimers is transported into the nucleus independently of 
p65 and NLS-deficient p65 cannot function as dominant negative for nuclear import 
of cellular p50. Furthermore, when we cotransfected the cells with NLS defective 
p52 and wt p50 or vice versa, we found that the NLS defective forms of these 
proteins did not have any effect on the cellular distribution of the heterologous wt 
proteins (IV, Figure 9). This indicates the tendency of p50 and p52 to form 
homodimers, at least when transfected and overexpressed together. 
To study whether there is a cross-regulation in the nuclear import of RelB and p52, 
we carried out cotransfection experiments with wt and NLS defective forms of p52 
and RelB. As expected, when transfected together, wt p52 and RelB colocalized in 
the cell nucleus. Interestingly, when NLS-mutant p52 was transfected with wt RelB, 
both proteins were transported into the nucleus, where they clearly colocalized. 
Furthermore, when the cells were transfected with wt p52 and NLS mutant RelB, wt 
p52 colocalized effectively with NLS defective RelB in the cell cytoplasm (IV, 
Figure 7). These data indicate that the nuclear import of p52/RelB heterodimers is 
regulated exclusively by the newly characterized NLS of RelB. An additional 
interesting observation was that the NLS of p52 protein was the dominant signal for 
the nuclear localization of the heterodimeric p52/p65 complexes (IV, Figure 8). The 
data show that, in contrast to the p52/RelB heterodimer, the nuclear import of 
heterodimeric p52/p65 complexes is regulated by the NLS of the p52 protein.     
The data presented here indicate that importin α family members clearly have 
distinct substrate specificities in nuclear import of NF-κB proteins. Based on the 
results from the binding experiments of in vitro-translated and endogenous NF-κB 
proteins presented above, it can be concluded that the specificity to a given NF-κB 
protein is also different and changes upon the composition of the imported dimer. 
Furthermore, the results presented here show that the NF-κB components of the 
classical and alternative pathways have somewhat different specificities for importin 
α molecules. 
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6 CONCLUSIONS 
Cells respond to various extracellular and intracellular stimuli with the activation of 
specific signal transduction pathways, leading to changes in host cell gene 
expression profiles in the nucleus. Many signalling molecules, which function as 
transcription factors must traverse the barrier of the nuclear envelope to gain access 
to the target genes. The main focus of this study was to characterize the mechanisms 
involved in the nuclear import of STAT1, STAT2 and NF-κB transcription factors.    
The present study demonstrates that STAT1 homodimers and STAT1/STAT2 
heterodimers are transported into the nucleus specifically by importin α5 molecule. 
These observations, togethter with previous findings, indicate that STATs use two 
different pathways for nuclear import. Before cytokine induction unphosphorylated 
STATs translocate into the nucleus by a carrier- or, at least, importin α-independent 
mechanism, that could involve interactions with nucleoporins. Nuclear import of 
tyrosine-phosphorylated STAT dimers, on the other hand, is dependent on the dimer-
specific NLSs of STATs, importin α5 molecules, RanGTPase and metabolic energy. 
We found that all NF-κB proteins are transported into the nucleus by a subset of 
importin α molecules. These results are the first to describe interactions of NF-κB 
proteins with importin α molecules. In our experimental settings we did not observe 
any association of IκBα with the NF-κB/importin α complexes. This indicates that 
NF-κB/IκBα complexes are not transported into the nucleus as a whole or, at least, 
not by the classical importin α mediated nuclear import pathway. Furthermore, the 
results presented here show that the NF-κB components of the classical and 
alternative pathways have somewhat different specificities to importin α molecules. 
Moreover, most likely due to the different NF-κB dimers existing under different 
cellular conditions, the specificity of importin α molecules to a given NF-κB family 
member is dependent on and changed by the composition of the proteins in the 
transported dimer. However, at present it is still unclear what is the contribution of 
specific NF-κB complexes to a given physiological response. Therefore, it is 
difficult to determine what would be the specificity of a given NF-κB dimer to 
distinct importin α family members under particular stimulus, and whether this 
specificity changes among different cellular conditions. 
The observations in the present work have taken a clear step forward in 
understanding the molecular mechanisms mediating the transport of STAT and NF-
κB transcription factors from the cytoplasm into the nucleus. Furthermore, these 
results provide additional evidence for the existence of distinct substrate specificities 
among importin α isoforms. In addition, this work shows that importin α molecules 
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are apparently more flexible than previously anticipated, since they can use both the 
N-terminal and the C-terminal NLS binding sites for binding to various proteins 
destined for nuclear import. 
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